var title_f36_2_36896="Anatomy sliding hiatus hernia";
var content_f36_2_36896=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anatomic features of sliding hiatus hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Representation of the anatomic features of a sliding hiatus hernia viewed radiographically during swallowing. The \"A\" ring is a muscular ring visible during swallowing which demarcates the superior margin of the lower esophageal sphincter. The \"B\" ring at the squamocolumnar junction is present in only about 15 percent of individuals; it permits accurate division of the phrenic ampulla into the esophageal vestibule (A ring to B ring) and the sliding hiatus hernia (B ring to the subdiaphragmatic stomach). Rugal folds traversing the hiatus support the conviction that a portion of the stomach is supradiaphragmatic.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kahrilas PJ. Hiatus hernia causes reflux: Fact or fiction? Gullet 1993; 3(Suppl):21.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36896=[""].join("\n");
var outline_f36_2_36896=null;
var title_f36_2_36897="Posterior vaginal wall prolapse 3";
var content_f36_2_36897=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Repair of posterior vaginal wall prolapse",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 372px; height: 451px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The rectovaginal musclaris is plicated in the midline using interrupted 0-delayed absorbable sutures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Walters, MD, Karram, MM. Urogynecology and reconstructive pelvic surgery, 3rd ed, Mosby-Elsevier, 2007. Copyright &copy;2007 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36897=[""].join("\n");
var outline_f36_2_36897=null;
var title_f36_2_36898="Patient information: Diabetic ketoacidosis (The Basics)";
var content_f36_2_36898=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?0/14/227\">",
"         Patient information: Hemoglobin A1C tests (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?21/40/22144\">",
"         Patient information: The ABCs of diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?15/49/16147\">",
"         Patient information: Treatment for type 2 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?0/43/692\">",
"         Patient information: Type 1 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/44/33475\">",
"         Patient information: Type 2 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?34/31/35317\">",
"         Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/26/36259\">",
"         Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?18/28/18886\">",
"         Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/22/9572\">",
"         Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/37/36436\">",
"         Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?40/1/40980\">",
"         Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?38/43/39603\">",
"         Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Diabetic ketoacidosis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/diabetic-ketoacidosis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H30186553\">",
"      <span class=\"h1\">",
"       What is diabetic ketoacidosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Diabetic ketoacidosis is a serious problem that happens to people with diabetes when chemicals called &ldquo;ketones&rdquo; build up in their blood. Normally, the body breaks down sugar as a source of energy. But in people with diabetes, the body is unable to use sugar. When the body can&rsquo;t use sugar, it burns fat as a source of energy. But burning fat can cause the body to make too many ketones. When ketones build up in the blood, they can be toxic.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30186568\">",
"      <span class=\"h1\">",
"       What causes diabetic ketoacidosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People can get diabetic ketoacidosis for a few reasons:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        They are not getting treated for diabetes (possibly because they don&rsquo;t know they have it) and so their body is breaking down fat.",
"       </li>",
"       <li>",
"        They have a major illness or health problem, such a heart attack or infection.",
"       </li>",
"       <li>",
"        They take certain medicines or illegal drugs.",
"       </li>",
"       <li>",
"        They don&rsquo;t take their insulin as directed.",
"       </li>",
"       <li>",
"        Their insulin pump does not work correctly.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30186583\">",
"      <span class=\"h1\">",
"       What are the symptoms of diabetic ketoacidosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feeling very thirsty and drinking a lot",
"       </li>",
"       <li>",
"        Urinating a lot, including at night",
"       </li>",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"       <li>",
"        Belly pain",
"       </li>",
"       <li>",
"        Feeling tired or having trouble thinking clearly",
"       </li>",
"       <li>",
"        Having breath that smells sweet or fruity",
"       </li>",
"       <li>",
"        Weight loss",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30186598\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse right away if you have the symptoms listed above. Also, see your doctor or nurse if your blood sugar levels keep being higher than they should be.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30186613\">",
"      <span class=\"h1\">",
"       Is there a test for diabetic ketoacidosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If the doctor or nurse thinks you have diabetic ketoacidosis, he or she will order several blood tests, including tests to check your blood sugar and ketone levels. He or she will also check your urine for ketones. These tests can show whether you have diabetic ketoacidosis.",
"     </p>",
"     <p>",
"      Because diabetic ketoacidosis can cause problems with the heart, you might also need an electrocardiogram. That is a test to measure the electrical activity in the heart.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30186628\">",
"      <span class=\"h1\">",
"       How is diabetic ketoacidosis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment is done at the hospital and can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Fluids and electrolytes &ndash; When dealing with diabetic ketoacidosis, the body loses a lot of fluids. It also loses electrolytes, chemicals such as sodium and potassium, that keep cells working normally. As part of treatment for the condition, doctors must replace lost fluids and electrolytes.",
"       </li>",
"       <li>",
"        Insulin &ndash; When the body has enough insulin, it can use sugar as fuel and it does not need to break down fat.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30186643\">",
"      <span class=\"h1\">",
"       Can diabetic ketoacidosis be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can reduce your chances of getting diabetic ketoacidosis by:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Taking your insulin exactly as directed",
"       </li>",
"       <li>",
"        Measuring your blood sugar often to make sure it is not too high or too low",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30186658\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/43/692?source=see_link\">",
"       Patient information: Type 1 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/44/33475?source=see_link\">",
"       Patient information: Type 2 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/49/16147?source=see_link\">",
"       Patient information: Treatment for type 2 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/40/22144?source=see_link\">",
"       Patient information: The ABCs of diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/14/227?source=see_link\">",
"       Patient information: Hemoglobin A1C tests (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/26/36259?source=see_link\">",
"       Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/31/35317?source=see_link\">",
"       Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/22/9572?source=see_link\">",
"       Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/37/36436?source=see_link\">",
"       Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/28/18886?source=see_link\">",
"       Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?38/43/39603?source=see_link\">",
"       Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/1/40980?source=see_link\">",
"       Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?36/2/36898?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17051 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-BBD231414A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36898=[""].join("\n");
var outline_f36_2_36898=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30186553\">",
"      What is diabetic ketoacidosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30186568\">",
"      What causes diabetic ketoacidosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30186583\">",
"      What are the symptoms of diabetic ketoacidosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30186598\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30186613\">",
"      Is there a test for diabetic ketoacidosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30186628\">",
"      How is diabetic ketoacidosis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30186643\">",
"      Can diabetic ketoacidosis be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30186658\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/31/35317?source=related_link\">",
"      Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/26/36259?source=related_link\">",
"      Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/28/18886?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/22/9572?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/37/36436?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/14/227?source=related_link\">",
"      Patient information: Hemoglobin A1C tests (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/1/40980?source=related_link\">",
"      Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?38/43/39603?source=related_link\">",
"      Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/40/22144?source=related_link\">",
"      Patient information: The ABCs of diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/49/16147?source=related_link\">",
"      Patient information: Treatment for type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/43/692?source=related_link\">",
"      Patient information: Type 1 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/44/33475?source=related_link\">",
"      Patient information: Type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_2_36899="Mafenide: Drug information";
var content_f36_2_36899=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Mafenide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?37/41/38548?source=see_link\">",
"    see \"Mafenide: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?10/28/10691?source=see_link\">",
"    see \"Mafenide: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190673\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sulfamylon&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F190686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F190674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Burns: Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream: Apply once or twice daily with a sterile-gloved hand; apply to a thickness of approximately",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      16",
"     </sub>",
"     inch; the burned area should be covered with cream at all times",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution: Cover graft area with 1 layer of fine mesh gauze. Wet an 8-ply burn dressing with mafenide solution and cover graft area. Keep dressing wet using syringe or irrigation tubing every 4 hours (or as necessary), or by moistening dressing every 6-8 hours (or as necessary). Irrigation dressing should be secured with bolster dressing and wrapped as appropriate. May leave dressings in place for up to 5 days.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F190681\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?10/28/10691?source=see_link\">",
"      see \"Mafenide: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F190675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F4302935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acidosis: Discontinuing treatment for 24-48 hours may aid in restoring acid-base balance",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F190660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sulfamylon&reg;: 85 mg/g (56.7 g, 113.4 g, 453.6 g) [contains sodium metabisulfite]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for solution, topical, as acetate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sulfamylon&reg;: 50 g/packet (5s)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F190646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F4303178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cream: Keep burn area covered with cream at all times; use thinner layer if dressings are used. Apply to clean debrided area with a sterile gloved hand",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F190661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream: Adjunctive antibacterial agent in the treatment of second- and third-degree burns",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution: Adjunctive antibacterial agent for use under moist dressings over meshed autografts on excised burn wounds",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F190684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Edema, facial edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Erythema, maceration, pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperchloremia, metabolic acidosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (following accidental ingestion)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Bleeding, bone marrow suppression, DIC, eosinophilia, hemolytic anemia, porphyria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Blisters, burning sensation, excoriation, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, hyperventilation, pCO",
"     <sub>",
"      2",
"     </sub>",
"     decreased, tachypnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F190665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to mafenide or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F190650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfonamide allergy: Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). Use in patients with sulfonamide allergy is specifically contraindicated in product labeling, however, a risk of cross-reaction exists in patients with allergy to any of these compounds; avoid use when previous reaction has been severe.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; G6PD deficiency: Use caution in patients with G6PD deficiency; may increase risk of DIC or hemolytic anemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; accumulation of parent drug and metabolite may enhance carbonic anhydrase inhibition and increase risk of metabolic acidosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage forms specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfites: Some dosage forms contain sulfites which may cause allergic reactions in certain individuals.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F190654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F190656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F4302933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies using an oral preparation. Safety and efficacy have not been established in pregnant women. The manufacturer does not recommended use in women of childbearing potential unless the burn area covers &gt;20% of the total body surface or when benefits of treatment outweigh possible risks to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F190678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Sulfamylon External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     85 mg/g (113.4 g): $75.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pack",
"     </b>",
"     (Sulfamylon External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (1): $122.50",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F190658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acid base balance; signs of infection; signs of healing",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Homonal (JP);",
"     </li>",
"     <li>",
"      Mafatate (JP);",
"     </li>",
"     <li>",
"      Mefede (KP);",
"     </li>",
"     <li>",
"      Sulfamylon (KP);",
"     </li>",
"     <li>",
"      Sulfomyl (GB)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F190649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As a sulfonamide, mafenide interferes with bacterial folic acid synthesis through competitive inhibition of para-aminobenzoic acid. Spectrum of activity encompasses both gram positive and negative organisms, including",
"     <i>",
"      Pseudomonas",
"     </i>",
"     and some anaerobes.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F190664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Diffuses through devascularized areas and is rapidly absorbed from burned surface",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: To para-carboxybenzene sulfonamide; mafenide and metabolite are carbonic anhydrase inhibitors",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: Cream 11%: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Burn tissue: Cream 11%: 2 hours, Solution 5%: 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9579 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.22.229.50-9649136F8B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36899=[""].join("\n");
var outline_f36_2_36899=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190673\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190686\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190674\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190681\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190675\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4302935\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190660\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190646\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303178\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190661\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190684\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190665\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190650\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299625\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190654\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190656\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4302933\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190678\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323349\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190658\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038668\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190649\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190664\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9579\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9579|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?37/41/38548?source=related_link\">",
"      Mafenide: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?10/28/10691?source=related_link\">",
"      Mafenide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_2_36900="Diethylene triamine penta-acetic acid: Drug information";
var content_f36_2_36900=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Diethylene triamine penta-acetic acid: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10362528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ca-DTPA;",
"     </li>",
"     <li>",
"      Zn-DTPA",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F159769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidote",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F159752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Internal contamination with plutonium, americium, or curium: Note:",
"     </b>",
"     Calcium diethylene triamine penta-acetic acid (Ca-DTPA) is the preferred initial agent if used within 24 hours of internal contamination; sequential administration of Ca-DTPA then zinc diethylene triamine penta-acetic acid (Zn-DTPA) is recommended. I.V., inhalation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Initial: Ca-DTPA: 1 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pregnancy: Zn-DTPA 1 g/day should be used for the initial dose in pregnant women",
"     <b>",
"      except",
"     </b>",
"     in cases of high internal contamination,",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maintenance: Zn-DTPA: 1 g/day; length of therapy depends on patient response and degree of contamination.",
"     <b>",
"      Note:",
"     </b>",
"     An equivalent dose of Ca-DTPA should be used for maintenance therapy only if Zn-DTPA is not available.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F159763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Internal contamination with plutonium, americium, or curium: Note:",
"     </b>",
"     Calcium diethylene triamine penta-acetic acid (Ca-DTPA) is the preferred initial agent if used within 24 hours of internal contamination; sequential administration of Ca-DTPA then zinc diethylene triamine penta-acetic acid (Zn-DTPA) is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Children &lt;12 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Initial: Ca-DTPA: 14 mg/kg/day (maximum dose: 1 g/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maintenance: Zn-DTPA: 14 mg/kg/day (maximum: 1 g/day); length of therapy depends on patient response and degree of contamination.",
"     <b>",
"      Note:",
"     </b>",
"     An equivalent dose of Ca-DTPA should be used for maintenance therapy only if Zn-DTPA is not available.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V., inhalation: Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F159753\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F159754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary; however, dialysis may be used to increase the rate of elimination after the initial dose. If calcium diethylene triamine penta-acetic acid (Ca-DTPA) is not available, substitute zinc diethylene triamine penta-acetic acid (Zn-DTPA) as initial therapy.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F159732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ca-DTPA: 200 mg/mL (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zn-DTPA: 200 mg/mL (5 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F159720\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F159734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dose should be administered once daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion: Administer over 30 minutes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V. push: Administer over 3-4 minutes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Nebulization: Patients should be instructed not to swallow any expectorant.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F159733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of known or suspected internal contamination with plutonium, americium, or curium",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F159767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, fever, headache, lightheadedness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Dermatitis, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Magnesium depletion, manganese depletion, zinc depletion (calcium diethylene triamine penta-acetic acid [Ca-DTPA])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, metallic taste, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Muscle cramps, pelvic pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough and/or wheezing (nebulization in patients with asthma)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F13795556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F159722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Administer via nebulization with caution in patients with asthma; may result in asthma exacerbations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hemochromatosis: Calcium diethylene triamine penta-acetic acid (Ca-DTPA) should be used with caution in patients with hemochromatosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neptunium, radioactive iodine, or uranium exposure: Treatment with DTPA is not effective for neptunium, radioactive iodine, or uranium exposure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Radioactive materials chelated to diethylene triamine penta-acetic acid (DTPA) are excreted renally; dialysis may be considered in patients with renal impairment to increase the rate of excretion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ca-DTPA: Use is associated with the depletion of endogenous trace metals (zinc, magnesium, manganese). The amount of depletion is dependent upon the length of therapy; vitamin and mineral supplements containing zinc should be provided. The initial treatment dose should be with Ca-DTPA; if additional doses are needed, zinc DTPA (Zn-DTPA) should be used if available due to safety concerns.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Zn-DTPA: Long-term use may be associated with the depletion of magnesium and manganese; vitamin and mineral supplements should be provided.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Administration: For I.V. administration; may also be administered by nebulization in adults whose contamination is only by inhalation within the last 24 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Treatment is most effective if initiated within 24 hours but should be started as soon as available; efficacy decreases with time following exposure as the radiocontaminants become sequestered in liver and bone. When given within the first day after internal contamination, Ca-DTPA is approximately 10 times more effective than Zn-DTPA at chelating plutonium, americium, and curium. After 24 hours have passed, both are equally efficacious (CDC, 2006). Patients should maintain adequate hydration and urinate frequently to minimize radiation exposure directly to the bladder.  Appropriate safety measures should be taken to minimize contamination of others.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F159726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F159728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     C (calcium diethylene triamine penta-acetic acid [Ca-DTPA]) (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     B (zinc diethylene triamine penta-acetic acid [Zn-DTPA]) (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F159738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have been reported with calcium diethylene triamine penta-acetic acid (Ca-DTPA) in animal studies. Multiple doses during pregnancy may increase adverse effects to the fetus due to zinc depletion. Reproduction studies with zinc diethylene triamine penta-acetic acid (Zn-DTPA) did not show teratogenic effects in animals; there are no well-controlled studies in pregnant women.  Except in cases of high internal contamination, treatment should be initiated and maintained with Zn-DTPA during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F159758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F159739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Radiocontaminants such as plutonium, americium, or curium can be found in breast milk; excretion of calcium diethylene triamine penta-acetic acid (Ca-DTPA) or zinc diethylene triamine penta-acetic acid (Zn-DTPA) is unknown. Women suspected of internal contamination, regardless of treatment, should not breast feed and precautions should be taken when discarding breast milk.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F159740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Fluids should be consumed liberally to promote dilution and excretion of radioactive chelate and minimize radiation exposure to bladder. Supplemental zinc or other vitamins and minerals may be needed.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Pentetate Calcium Trisodium Combination)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/mL (5 mL): $90.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Pentetate Zinc Trisodium Combination)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/mL (5 mL): $90.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F159730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential, BUN, urinalysis, blood and urine radioassays (baseline and throughout therapy); blood, urine, and fecal radioactivity (weekly); serum essential metals (eg, magnesium, manganese, zinc)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F159721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Calcium diethylene triamine penta-acetic acid (Ca-DTPA) and zinc diethylene triamine penta-acetic acid (Zn-DTPA) form chelates with some metal ions by exchanging calcium or zinc for a metal of greater binding capacity. The radioactive chelates are then excreted in the urine. Treatment is most effective when radiocontaminants are in circulation or interstitial fluids. Radiocontaminants eventually sequester in liver and bone; therefore, the efficacy of treatment decreases with time after the exposure.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F159736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Calcium diethylene triamine penta-acetic acid (Ca-DTPA): Oral: Poor (~5%); Inhalation: 20%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zinc diethylene triamine penta-acetic acid (Zn-DTPA): Oral: Poor (~5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Ca-DTPA, Zn-DTPA: Distributed throughout extracellular fluid; not found to accumulate in organs",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Ca-DTPA, Zn-DTPA: Minimal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Ca-DTPA, Zn-DTPA: May be increased by renal impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Ca-DTPA, Zn-DTPA: Urine; Rate of excretion may be decreased by renal impairment Ca-DTPA provides a 10-fold higher rate of radioactivity elimination than Zn-DTPA within the first 24 hours; after 24 hours rate of radioactivity elimination is comparable.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Berard P, Michel X, Menetrier F, et al, &ldquo;Medical Management of a Cutaneous Contamination,&rdquo;",
"      <i>",
"       Health Phys",
"      </i>",
"      , 2010, 99(4):572-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/2/36900/abstract-text/20838101/pubmed\" id=\"20838101\" target=\"_blank\">",
"        20838101",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carbaugh EH, Lynch TP, Cannon CN, et al, &ldquo;Case Study: Three Acute 241Am Inhalation Exposures With DTPA Therapy,&rdquo;",
"      <i>",
"       Health Phys",
"      </i>",
"      , 2010, 99(4):539-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/2/36900/abstract-text/20838096/pubmed\" id=\"20838096\" target=\"_blank\">",
"        20838096",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Radiation Emergencies Fact Sheet: Diethylenetriamene Pentaacetate (DTPA),\" October 11, 2006. Available at",
"      <a href=\"file://emergency.cdc.gov/radiation/dtpa.asp\" target=\"_blank\">",
"       file://emergency.cdc.gov/radiation/dtpa.asp",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8729 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-188.40.116.55-6D8648E745-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36900=[""].join("\n");
var outline_f36_2_36900=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10362528\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159769\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159752\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159763\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159753\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159754\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159732\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159720\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159734\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159733\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159767\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13795556\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159722\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299189\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159726\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159728\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159738\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159758\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159739\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159740\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323110\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159730\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159721\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159736\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8729\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8729|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_2_36901="Pathophysiology and stages of chronic mitral regurgitation";
var content_f36_2_36901=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathophysiology and stages of chronic mitral regurgitation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36901/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36901/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36901/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36901/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36901/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36901/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/2/36901/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic mitral regurgitation (MR) is a relatively common valvular disorder that can progress to ventricular decompensation and the need for mitral valve surgery. The pathophysiology and stages of chronic MR will be reviewed here. The etiology, clinical features, natural history, and overview of management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/30/9705?source=see_link\">",
"     \"Etiology, clinical features, and evaluation of chronic mitral regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/31/6649?source=see_link\">",
"     \"Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/51/33593?source=see_link\">",
"     \"Overview of the management of chronic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CARDIAC RESPONSE TO MR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral regurgitation burdens the left ventricle with an excessive volume load that leads to a series of compensatory myocardial and circulatory adjustments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. These adjustments vary over the prolonged course of the disorder, so that the changes that are operative in acute or subacute MR are eventually replaced by other compensatory mechanisms. Finally, the myocardium fails, the ventricle decompensates, and the patient exhibits signs of heart failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Acute MR",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two major hemodynamic changes with acute MR and LV volume overload:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ventricle utilizes its preload reserve, resulting in an increase in total stroke volume via the Frank-Starling mechanism.",
"     </li>",
"     <li>",
"      The low resistance runoff into the left atrium results in an increase in ejection fraction and a reduction in systolic volume. According to the law of Laplace, the fall in systolic volume is associated with a decline in systolic load (ie, afterload) (",
"      <a class=\"graphic graphic_figure graphicRef58408 \" href=\"mobipreview.htm?40/2/41003\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, in acute MR, an increase in LV preload and a decrease in afterload result in increases in ejection fraction and total stroke volume. The major burden and threat is to the pulmonary venous circulation and the lungs, sometimes leading to pulmonary edema. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/41/3737?source=see_link\">",
"     \"Hemodynamics of valvular disorders as measured by cardiac catheterization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/45/28376?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Chronic compensated MR",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major change that occurs during the evolution from acute to chronic MR is an enlargement of the left ventricle (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75174 \" href=\"mobipreview.htm?11/59/12213\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef75955 \" href=\"mobipreview.htm?16/31/16884\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef65598 \" href=\"mobipreview.htm?35/3/35892\">",
"     movie 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef50961 \" href=\"mobipreview.htm?7/63/8178\">",
"     movie 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef54431 \" href=\"mobipreview.htm?33/59/34740\">",
"     movie 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef73594 \" href=\"mobipreview.htm?28/11/28850\">",
"     movie 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef52748 \" href=\"mobipreview.htm?24/60/25539\">",
"     movie 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef63107 \" href=\"mobipreview.htm?8/37/8784\">",
"     movie 7",
"    </a>",
"    ). Doppler echocardiography may provide important information about the severity of MR. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/51/33593?source=see_link\">",
"     \"Overview of the management of chronic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As this new steady state develops, the small hyperkinetic chamber of acute MR is converted into a large compliant chamber that is well suited to deliver a large stroke volume. This comes about through a rearrangement of myocardial fibers, with the addition of new sarcomeres and the development of eccentric LV hypertrophy. The net effect is that the changes in LV loading conditions seen in acute MR tend to be reversed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Despite LV chamber enlargement, preload at the level of the sarcomere returns toward normal or near normal levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The systolic unloading that is characteristic of acute MR is gradually replaced by normal systolic wall stresses (afterload) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the enhanced total stroke volume seen in chronic compensated mitral regurgitation is \"mediated through a normal performance of each unit of an enlarged circumference\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/6\">",
"     6",
"    </a>",
"    ]. In other words, LV contractility, loading conditions (sarcomere length and afterload), and ejection fraction remain within the range of normal with the large end-diastolic volume being responsible for the enhanced total stroke volume. An enlarged compliant atrium contributes to a decline in pulmonary venous pressures. During this compensated phase of the disease, most patients remain asymptomatic, rhythm disturbances are uncommon, and corrective surgery is generally postponed.",
"   </p>",
"   <p>",
"    Although these patients appear to be asymptomatic, some have impaired functional capacity and reduced exercise tolerance. The degree of functional impairment is, however, an unreliable guide to disease severity or left ventricular dysfunction. In some such patients, physical deconditioning contributes to functional impairment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Transition to heart failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;An elusive and poorly understood aspect of the pathophysiology of MR is the nature of the transition from the compensated to a decompensated state. Such a change may occur as a consequence of progressive increments in the regurgitant volume",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chamber size. The decompensated state is characterized by substantial and progressive ventricular enlargement with increased LV diastolic pressures, increased systolic wall stress, and a decline in the ejection fraction; the fall in ejection fraction is due both to a depressed contractile state and to excessive afterload. These changes in LV size and function are often accompanied by progressive atrial enlargement, atrial arrhythmias, pulmonary hypertension, and eventually the signs and symptoms of congestive heart failure.",
"   </p>",
"   <p>",
"    Some patients experience fatigue, a limited exercise tolerance, or even dyspnea during this transition. In such patients, the decision to proceed with surgery is relatively easy and the results are generally good. Other patients, however, may proceed through the transition period and show evidence of LV dysfunction with minimal or no symptoms. Such patients have reached a late decompensated stage in which the LV and left atrial dysfunction become irreversible and it may be too late to expect an optimal result from corrective surgery.",
"   </p>",
"   <p>",
"    If an optimal response to surgery is the goal, it is important to identify such a patient before the development of irreversible changes in ventricular function. This can be achieved by considering the markers of a decompensated ventricle and developing guidelines for the identification of the stage of transition from compensated to decompensated MR.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     MARKERS OF A DECOMPENSATED VENTRICLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiographic and angiographic indices of LV size and function play a critical role in the definition of a decompensated ventricle. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32409?source=see_link\">",
"     \"Echocardiographic evaluation of the mitral valve\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/3/42040?source=see_link\">",
"     \"Transesophageal echocardiography in the evaluation of mitral valve disease\"",
"    </a>",
"    .) The decompensated state as defined herein is",
"    <strong>",
"     not",
"    </strong>",
"    based upon semiquantitative estimation of the severity of regurgitation obtained from cine angiography or Doppler echocardiography.",
"   </p>",
"   <p>",
"    Clinical investigators have studied the temporal changes in LV size and function before and after mitral valve replacement in patients with chronic MR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Approximately 75 percent of the reported patients exhibited a postoperative decline in LV chamber size and a significant regression of LV hypertrophy; the remaining patients had persistent postoperative LV enlargement and systolic dysfunction.",
"   </p>",
"   <p>",
"    These two groups had distinctly different preoperative indices of LV size and function. In particular, the patients with a suboptimal ventricular response to valve replacement could be identified by the following preoperative echocardiographic parameters:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      LV end-diastolic dimension exceeding 70 mm",
"     </li>",
"     <li>",
"      LV end-systolic dimension exceeding 47 mm",
"     </li>",
"     <li>",
"      A low normal or depressed LV ejection fraction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prognostic importance of an end-systolic diameter above 47 mm has been confirmed in a later study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/9\">",
"     9",
"    </a>",
"    ]. This echocardiographic dimension translates into an end-systolic volume of approximately 50",
"    <span class=\"nowrap\">",
"     mL/m2,",
"    </span>",
"    which is in close agreement with the angiographic data in other reports (",
"    <a class=\"graphic graphic_table graphicRef79918 \" href=\"mobipreview.htm?34/11/35003\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exercise echocardiography has been used to predict left ventricular function after mitral valve repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients with a postoperative ejection fraction below 50 percent were compared to those with higher values. The patients with a postoperative ejection fraction below 50 percent had significantly lower preoperative ejection fractions (57 versus 73 percent, p&lt;0.0005), larger exercise end-systolic volume index (32 versus 18",
"    <span class=\"nowrap\">",
"     cm3/m2,",
"    </span>",
"    p&lt;0.0005), and a smaller change in ejection fraction with exercise (-4 versus 9 percent). An exercise end-systolic volume index above 25",
"    <span class=\"nowrap\">",
"     cm3/m2",
"    </span>",
"    was the best predictor of postoperative left ventricular dysfunction (sensitivity and specificity of 83 percent).",
"   </p>",
"   <p>",
"    Patients who exhibit one or more of these markers of a decompensated ventricle are at high risk of persistent postoperative LV enlargement, depressed postoperative ventricular function, and a poor or suboptimal clinical result. While these considerations do not identify the optimal time for mitral valve replacement or repair, they do enable the clinician to predict a poor LV response to corrective surgery and, in this fashion, provide a picture of the options of surgical or nonsurgical treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/14\">",
"     14",
"    </a>",
"    ]. On the other hand, the",
"    <strong>",
"     compensated",
"    </strong>",
"    stage in chronic MR is defined largely on the basis of natural history and other data that indicate a benign prognosis when the end-diastolic dimension is less than 60 mm and the end-systolic dimension is less than 40 mm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recognizing that these stages and their prognostic implications have not been statistically validated in a prospective fashion, they should be used only as general guidelines in a decision analysis that includes other clinical data including patient preferences (",
"    <a class=\"graphic graphic_table graphicRef79918 \" href=\"mobipreview.htm?34/11/35003\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4802607\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a holosystolic murmur or other evidence of hemodynamically significant MR should have an echocardiogram at the time of their initial evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    .) Serial monitoring to identify evidence of impending decompensation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/51/33593?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of the management of chronic mitral regurgitation\", section on 'Serial monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4802418\">",
"    <span class=\"h1\">",
"     RATIONALE FOR MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although definitive prospective studies are not available, it is possible to develop a rationale for the management of chronic MR that is based on an understanding of the pathophysiology and stages of MR, the natural history of the disease, and the therapeutic potential of medical and surgical treatments. Management of chronic MR is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/51/33593?source=see_link\">",
"     \"Overview of the management of chronic mitral regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/32/25096?source=see_link\">",
"     \"Indications for corrective surgery in severe chronic primary mitral regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29109?source=see_link\">",
"     \"Vasodilator therapy in chronic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In summary, asymptomatic patients with only modest LV enlargement and normal systolic function (ie, compensated MR) can generally be treated conservatively. Ideally, corrective surgery should be performed during the period of transition from a compensated to decompensated stage. Vasodilator therapy may be useful during the transitional stage. Those with evidence of a decompensated ventricle have little to gain from postponing surgery, even though they may not expect an optimal surgical result [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36901/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mitral regurgitation burdens the left ventricle with an excessive volume load that leads to a series of compensatory myocardial and circulatory adjustments. These compensatory adjustments vary over the prolonged course of the disorder. In severe MR, the myocardium eventually fails, the ventricle decompensates, and the patient exhibits signs of heart failure. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Cardiac response to MR'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major change that occurs during the evolution from acute to chronic MR is an enlargement of the left ventricle. In chronic compensated MR, LV contractility, loading conditions, and ejection fraction remain within the normal range with the large end-diastolic volume being responsible for the enhanced total stroke volume. An enlarged compliant atrium contributes to a decline in pulmonary venous pressures. During this compensated phase of the disease, most patients remain asymptomatic. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Chronic compensated MR'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since patients may or may not experience symptoms during the transition from compensated to decompensated chronic MR, monitoring for evidence of decompensation, including periodic measurement of LV size and systolic function by echocardiography, is required. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Transition to heart failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who exhibit one or more of markers of a decompensated ventricle are at high risk of persistent postoperative LV enlargement, depressed postoperative ventricular function, and a poor or suboptimal clinical result. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Markers of a decompensated ventricle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of chronic MR should be based upon an understanding of the pathophysiology and natural history of this disorder. (See",
"      <a class=\"local\" href=\"#H4802418\">",
"       'Rationale for management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Gaasch, WH, Levine, HJ, Zile, MR. Chronic aortic and mitral regurgitation: Mechanical consequences of the lesion and the results of surgical correction. In: The Ventricle, Gaasch, WH, Levin, HJ (Eds), Martinus Nijhoff Publishing, Boston 1985. p.237.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/2\">",
"      Carabello BA. Mitral valve disease. Curr Probl Cardiol 1993; 18:423.",
"     </a>",
"    </li>",
"    <li>",
"     Gaasch, WH, O'Rourke, RA, Cohn, LH, Rackley, CE. Mitral valve disease. In: Hurst's The Heart, Schlant, RC, Alexander, RW (Eds), McGraw Hill, New York 1993. p.1483.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/4\">",
"      Ross J Jr, Sonnenblick EH, Taylor RR, et al. Diastolic geometry and sarcomere lengths in the chronically dilated canine left ventricle. Circ Res 1971; 28:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/5\">",
"      Gaasch WH, Zile MR. Left ventricular function after surgical correction of chronic mitral regurgitation. Eur Heart J 1991; 12 Suppl B:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/6\">",
"      Shah PM, Adelman AG, Wigle ED, et al. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res 1974; 35:suppl II:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/7\">",
"      Schuler G, Peterson KL, Johnson A, et al. Temporal response of left ventricular performance to mitral valve surgery. Circulation 1979; 59:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/8\">",
"      Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol 1984; 3:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/9\">",
"      Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994; 89:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/10\">",
"      Borow KM, Green LH, Mann T, et al. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med 1980; 68:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/11\">",
"      Carabello BA, Nolan SP, McGuire LB. Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio. Circulation 1981; 64:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/12\">",
"      Crawford MH, Souchek J, Oprian CA, et al. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation 1990; 81:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/13\">",
"      Leung DY, Griffin BP, Stewart WJ, et al. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 1996; 28:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/14\">",
"      Gaasch WH, John RM, Aurigemma GP. Managing asymptomatic patients with chronic mitral regurgitation. Chest 1995; 108:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/15\">",
"      Zuppiroli A, Rinaldi M, Kramer-Fox R, et al. Natural history of mitral valve prolapse. Am J Cardiol 1995; 75:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36901/abstract/16\">",
"      Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation 2008; 118:2298.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8163 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.12-587BC34546-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36901=[""].join("\n");
var outline_f36_2_36901=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CARDIAC RESPONSE TO MR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Acute MR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Chronic compensated MR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Transition to heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      MARKERS OF A DECOMPENSATED VENTRICLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4802607\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4802418\">",
"      RATIONALE FOR MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8163\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8163|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?11/59/12213\" title=\"diagnostic image 1\">",
"      CXR chronic MR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8163|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/2/41003\" title=\"figure 1\">",
"      The law of Laplace",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8163|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?16/31/16884\" title=\"movie 1\">",
"      Echo 4-chamber view MR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?35/3/35892\" title=\"movie 2\">",
"      Apical 4-chamber echocardiogram MR 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?7/63/8178\" title=\"movie 3\">",
"      Echo apical long axis view MR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?33/59/34740\" title=\"movie 4\">",
"      Echo MR post MI four chamber color Doppler echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?28/11/28850\" title=\"movie 5\">",
"      Echo MR in MI apical long axis color Doppler echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?24/60/25539\" title=\"movie 6\">",
"      Echo parasternal long axis post MI MR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?8/37/8784\" title=\"movie 7\">",
"      Echo four chamber severe MR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8163|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/11/35003\" title=\"table 1\">",
"      Echo stages of chronic MR",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32409?source=related_link\">",
"      Echocardiographic evaluation of the mitral valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/30/9705?source=related_link\">",
"      Etiology, clinical features, and evaluation of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/41/3737?source=related_link\">",
"      Hemodynamics of valvular disorders as measured by cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/32/25096?source=related_link\">",
"      Indications for corrective surgery in severe chronic primary mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/31/6649?source=related_link\">",
"      Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/51/33593?source=related_link\">",
"      Overview of the management of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/45/28376?source=related_link\">",
"      Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/3/42040?source=related_link\">",
"      Transesophageal echocardiography in the evaluation of mitral valve disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29109?source=related_link\">",
"      Vasodilator therapy in chronic mitral regurgitation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_2_36902="Amniotic band sequence";
var content_f36_2_36902=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Amniotic band sequence",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36902/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36902/contributors\">",
"     Olaf A Bodamer, MD, FACMG, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36902/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36902/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36902/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36902/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36902/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/2/36902/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniotic band sequence refers to a highly variable spectrum of congenital anomalies that occur in association with amniotic bands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. It is called a sequence because the pattern of congenital anomalies results from a single defect that can be produced by a variety of different etiologies. In contrast, a syndrome refers to a pattern of congenital anomalies that are known, or at least assumed, to result from only a single etiology.",
"   </p>",
"   <p>",
"    Heterogeneity in clinical manifestations, etiology, pathogenesis, and recurrence risk of amniotic band-associated anomalies has contributed to confusion regarding nomenclature. Historically, diverse terms have been used to describe these anomalies, including amniotic band sequence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/4,5\">",
"     4,5",
"    </a>",
"    ], amniotic band syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/7\">",
"     7",
"    </a>",
"    ], amniotic band disruption complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/8\">",
"     8",
"    </a>",
"    ], limb body wall complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/9,10\">",
"     9,10",
"    </a>",
"    ], body wall complex with limb defects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/11\">",
"     11",
"    </a>",
"    ], amniotic deformity, adhesion, and mutilation (ADAM) sequence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/12\">",
"     12",
"    </a>",
"    ], etc. We consider amniotic band sequence (ABS) the most appropriate term since the pattern of anomalies is secondary to disruption of heterogeneous etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/6\">",
"     6",
"    </a>",
"    ]. However, this nomenclature remains controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/6,11,13,14\">",
"     6,11,13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The estimated incidence of ABS ranges from 1:1200 to 1:15,000 in live births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/2\">",
"     2",
"    </a>",
"    ], and 1:70 in stillbirths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/5\">",
"     5",
"    </a>",
"    ]. It affects both sexes equally.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of both amniotic bands and ABS are not firmly established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Early amniotic rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;One hypothesis is that amniotic bands are related to rupture of the amnion. In these cases, loose strands of amnion are believed to adhere to and then entangle the",
"    <span class=\"nowrap\">",
"     embryo/fetus",
"    </span>",
"    or germ disc, resulting in mechanical or vascular disruption of otherwise normal developing structures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/1-4,9,10,15-17\">",
"     1-4,9,10,15-17",
"    </a>",
"    ]. As an example, amniotic bands that adhere to the developing limb, cranium, or body wall can compromise its blood supply leading to partial amputation. Other anomalies in ABS, such as lung hypoplasia, clubfoot, and hand deformities, have been related to oligohydramnios following amnion rupture.",
"   </p>",
"   <p>",
"    The cause of amnion rupture is uncertain in most cases, but associations with abdominal trauma during pregnancy and maternal or fetal diseases have been reported in some cases. \"Pseudoamniotic band syndrome\" has been used to describe cases due to iatrogenic rupture of the amnion from an invasive procedure (eg, fetoscopy, septostomy, amniocentesis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Vascular disruption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniotic bands not causally related to early amnion rupture are thought to be a secondary phenomena after a primary disruptive event. As an example, disruption of fetal blood flow might lead to several sequelae, including generation of amniotic bands and internal and external fetal malformations. Other evidence supporting a vascular etiology is the increased prevalence of internal visceral anomalies and other anomalies not readily explicable by the ABS and the frequent finding of disruptive defects in fetuses with a histologically normal intact amniotic lining [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/20\">",
"     20",
"    </a>",
"    ]. The presence of multiple or severe defects in some ABS cases suggests the occurrence of more than one disruptive factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/13,21\">",
"     13,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetic mutation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small subset of ABS cases have malformations that cannot be explained by disruption by external forces alone. In these cases, a genetic basis for the malformation, and thus the possibility of an increased risk of recurrence, should be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]. Mutations in the human homologue of the mouse gene Ds \"disorganization gene\" have been proposed as one mechanism for the combination of",
"    <span class=\"nowrap\">",
"     constriction/duplication",
"    </span>",
"    abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. Almost all cases of ABS in twins have been in monozygotic twins, which also suggests an etiology intrinsic to the fetus.",
"   </p>",
"   <p>",
"    Other intrinsic defects and environmental etiologies should also be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/13/7386?source=see_link\">",
"     \"Genetic and environmental causes of birth defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constriction rings and limb and digital amputation are common findings in ABS, but the clinical spectrum is highly variable. A single mild defect may be present or the fetus may be severely deformed, with multiple anomalies affecting cranium, spine, limbs, and trunk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Constriction rings are congenital depressions of tissue that encircle a portion of the body. In ABS, multiple constriction rings may be present that involve multiple digits and limbs. Fibrous bands of amnion can be found deep inside most of the constriction rings and may contribute to compromise of the vascular supply, as well as bone and nerves [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/17,26\">",
"     17,26",
"    </a>",
"    ]. If constriction results in amputation, the amputated body part is often resorbed, and thus will not be found at delivery.",
"   </p>",
"   <p>",
"    Anomalies include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/27\">",
"     27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Craniofacial abnormalities &mdash; eg, encephalocele, exencephaly, clefts, which are often in unusual locations; anencephaly.",
"     </li>",
"     <li>",
"      Body wall defects (especially if not in the midline), abdominal or thoracic contents may herniate through a body wall defect and into the amniotic cavity.",
"     </li>",
"     <li>",
"      Limb defects &mdash; constriction rings, amputation, syndactyly, clubfoot, hand deformities, lymphedema distal to a constriction ring.",
"     </li>",
"     <li>",
"      Visceral defects &mdash; eg, lung hypoplasia.",
"     </li>",
"     <li>",
"      Other &mdash; Autotransplanted tissue on skin tags, spinal defects, scoliosis, ambiguous genitalia, short umbilical cord due to restricted motion of the fetus",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of ABS is based upon the presence of characteristic structural findings on prenatal ultrasound or postnatal physical examination of the affected individual (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56307 \" href=\"mobipreview.htm?20/40/21123\">",
"     image 1",
"    </a>",
"    ). The diagnosis should be suspected when limb amputations or atypical body wall or craniofacial defects are present, or when bands of amnion are seen crossing the gestational sac and adherent to the fetus, restricting its movement (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69162 graphicRef70926 graphicRef63863 \" href=\"mobipreview.htm?17/13/17625\">",
"     image 2A-C",
"    </a>",
"    ). The diagnosis of ABS should not be based on visualization of amniotic abnormalities alone in the absence of fetal structural abnormalities or restricted movement. These amniotic variants may be seen in normal pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In most cases of prenatally detected ABS, however, the bands of amnion are not visualized sonographically, and only the fetal structural abnormalities are seen. Antenatal magnetic resonance imaging may be helpful in confirming the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If ABS is suspected postnatally, immediate investigation of the fresh fetal membranes and placenta is important. Amniotic strands can be visualized easily by immersion of fresh membranes and placenta into a tub of water. Care should be taken if there is frayed amnion or complete or partial separation of amnion from the chorion, so as not to create the appearance of amniotic bands postpartum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniotic sheets typically arise when chorioamniotic membranes wrap around uterine synechiae (intrauterine adhesions), thus they have two layers of amnion and two layers of chorion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/31\">",
"     31",
"    </a>",
"    ]. They commonly have a widened base along the uterine wall, and may extend to the contralateral uterine wall.",
"   </p>",
"   <p>",
"    Amniotic sheets occur in about 0.5 percent of pregnancies and are not associated with fetal anomalies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/32\">",
"     32",
"    </a>",
"    ]. They are usually considered to be an incidental benign finding, although two series observed an increase in some types of obstetric morbidity (eg, premature rupture of membranes, placental abruption, malpresentation) in pregnancies with amniotic sheets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/33,34\">",
"     33,34",
"    </a>",
"    ] and another described two stillbirths that were attributed to cord accidents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/35\">",
"     35",
"    </a>",
"    ]. Additional studies are needed to determine whether there is a true association between amniotic sheets and adverse pregnancy outcome.",
"   </p>",
"   <p>",
"    Heterogeneity in the clinical manifestations and etiology of ABS makes diagnosis particularly challenging. The differential diagnosis of a band of tissue seen in or impinging on the gestational sac includes uterine synechia, uterine septum, and residual twin gestational sac. These are typically relatively easy to diagnose, and are not associated with fetal anomalies of the type that occur in ABS. Fibrin strands that occur after in utero bleeding are usually obvious due to clinical history of bleeding or recent invasive procedure. These strands may be adherent to the fetus, but should change in appearance over time, and are not associated with fetal anomalies. Unfused amnion or chorioamniotic separation are typically diagnosed when a large section of unfused amnion is seen. If this persists, it may be associated with club foot, but the other anomalies of ABS do not occur. Acquired limb ischemia is a rare complication of monochorionic twin pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/36\">",
"     36",
"    </a>",
"    ]. The etiology is unclear, but, in some cases, it may be related to interventions for twin-twin transfusion syndrome.",
"   </p>",
"   <p>",
"    As limb and digital amputation are common findings in ABS, it is of particular importance to consider other etiologies of limb reduction defects, such as genetic and teratogenic causes. In general, limb reduction defects affecting the middle bone of multiple limbs are highly likely to be genetic, especially if they are symmetrical. For accurate assessment of the recurrence risk, it is of particular importance to not miss genetic diseases that may mimic ABS (eg, Adams-Oliver Syndrome, which has an autosomal dominant pattern of inheritance).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PREGNANCY MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prenatal and intrapartum management of suspected ABS depends on the type and extent of malformations. All patients should receive information about the fetal abnormalities that have been detected, the possibility of additional undetected abnormalities, prognosis, and the option of pregnancy termination. If pregnancy termination is performed, it is useful to try to deliver an intact abortus that can be examined to confirm the diagnosis.",
"   </p>",
"   <p>",
"    There have been case reports of in utero surgical lysis of constriction rings, purportedly leading to improved blood flow and prevention of amputation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/37-41\">",
"     37-41",
"    </a>",
"    ]. The efficacy of this approach is unproven and selection criteria for candidates for in utero intervention have not been defined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of miscarriage, preterm birth, and stillbirth appear to be increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/2,3,42\">",
"     2,3,42",
"    </a>",
"    ]. The postnatal prognosis in ABS depends on the severity of the anomalies, especially involvement of internal organs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/43\">",
"     43",
"    </a>",
"    ]. The spectrum varies from mild abnormalities with an excellent prognosis to severe anomalies that are lethal.",
"   </p>",
"   <p>",
"    Usually there is no progression in severity following birth, with the exception of cases with marked vascular occlusion due to constrictive bands. In early infancy, some of these cases might present with progressive edema distal to the constriction rings, which can be treated by surgical release. Rarely, necrosis distal to vascular occlusion might necessitate immediate surgical release [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seven cases of fetoscopic laser transection of amniotic bands around a limb have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/44\">",
"     44",
"    </a>",
"    ]. The procedures were performed between 20 and 28 weeks of gestation. In five cases, premature rupture of membranes occurred 4 days to 14.3 weeks after the procedure. There was one procedure related fetal death; four fetuses appeared to benefit from in utero therapy, but needed additional corrective postnatal surgical procedures; one fetus did not need additional postnatal surgical treatment, but had residual radial paresis and mild hypoplasia; and one fetus derived no significant benefit from in utero therapy and required amputation of its hand postnatally to allow fitting a prosthesis. The authors hypothesized that appropriate potential candidates for this investigational procedure would be fetuses with normal Doppler flow above the constriction and abnormal, but present, flow below the constriction.",
"   </p>",
"   <p>",
"    Postnatal treatment options include surgical intervention to enhance function or for cosmetic purposes, and prosthesis and physiotherapy for individuals with limb defects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     RECURRENCE RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrence risk is estimated based upon family history, patient history, and thorough physical examination. Most ABS is sporadic with low recurrence risk; however, a few familial cases have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/2,45-47\">",
"     2,45-47",
"    </a>",
"    ]. Genetic counseling to discuss recurrence risk is recommended if a genetic disease associated with amniotic bands is suspected (eg, epidermolysis bullosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/48\">",
"     48",
"    </a>",
"    ], or connective tissue disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36902/abstract/49\">",
"     49",
"    </a>",
"    ]).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Amniotic band sequence refers to a highly variable spectrum of congenital anomalies that occur in association with amniotic bands. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Etiology and pathogenesis are heterogeneous and controversial. Loose strands of amnion are believed to adhere to and then entangle the",
"      <span class=\"nowrap\">",
"       embryo/fetus",
"      </span>",
"      or germ disc, resulting in mechanical or vascular disruption of developing structures. A rare potential etiology is a mutation in a developmental gene. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical manifestations include limb and digital amputation, constriction rings, craniofacial abnormalities, body wall defects (especially if not in the midline), syndactyly, autotransplanted tissue on skin tags, clubfoot, hand deformities, spinal defects, and lung hypoplasia. Abdominal or thoracic contents may herniate through a body wall defect and into the amniotic cavity. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is based upon the presence of characteristic structural findings on prenatal ultrasound or postnatal physical examination. The diagnosis should be suspected when limb amputations or atypical body wall or craniofacial defects are present, or when bands of amnion are seen crossing the gestational sac and adherent to the fetus. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no in utero treatment. Postnatally, surgical correction and limb prostheses may be needed. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prognosis depends on the severity of the anomalies, especially involvement of internal organs. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/1\">",
"      Seeds JW, Cefalo RC, Herbert WN. Amniotic band syndrome. Am J Obstet Gynecol 1982; 144:243.",
"     </a>",
"    </li>",
"    <li>",
"     Stevenson, RE, Hall, JG. Human Malformations and related anomalies, 2nd ed, Oxford University Press 2006. p.871.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/3\">",
"      TORPIN R. AMNIOCHORIONIC MESOBLASTIC FIBROUS STRINGS AND AMNIONIC BANDS: ASSOCIATED CONSTRICTING FETAL MALFORMATIONS OR FETAL DEATH. Am J Obstet Gynecol 1965; 91:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/4\">",
"      Hunter AG, Carpenter BF. Implications of malformations not due to amniotic bands in the amniotic band sequence. Am J Med Genet 1986; 24:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/5\">",
"      Kalousek DK, Bamforth S. Amnion rupture sequence in previable fetuses. Am J Med Genet 1988; 31:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/6\">",
"      Mart&iacute;nez-Fr&iacute;as ML. Epidemiological characteristics of amniotic band sequence (ABS) and body wall complex (BWC): are they two different entities? Am J Med Genet 1997; 73:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/7\">",
"      Chemke J, Graff G, Hurwitz N, Liban E. The amniotic band syndrome. Obstet Gynecol 1973; 41:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/8\">",
"      Higginbottom MC, Jones KL, Hall BD, Smith DW. The amniotic band disruption complex: timing of amniotic rupture and variable spectra of consequent defects. J Pediatr 1979; 95:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/9\">",
"      Van Allen MI, Curry C, Gallagher L. Limb body wall complex: I. Pathogenesis. Am J Med Genet 1987; 28:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/10\">",
"      Van Allen MI, Curry C, Walden CE, et al. Limb-body wall complex: II. Limb and spine defects. Am J Med Genet 1987; 28:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/11\">",
"      Pagon RA, Stephens TD, McGillivray BC, et al. Body wall defects with reduction limb anomalies: a report of fifteen cases. Birth Defects Orig Artic Ser 1979; 15:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/12\">",
"      Orioli IM, Ribeiro MG, Castilla EE. Clinical and epidemiological studies of amniotic deformity, adhesion, and mutilation (ADAM) sequence in a South American (ECLAMC) population. Am J Med Genet A 2003; 118A:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/13\">",
"      Moerman P, Fryns JP, Vandenberghe K, Lauweryns JM. Constrictive amniotic bands, amniotic adhesions, and limb-body wall complex: discrete disruption sequences with pathogenetic overlap. Am J Med Genet 1992; 42:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/14\">",
"      Robin NH, Franklin J, Prucka S, et al. Clefting, amniotic bands, and polydactyly: a distinct phenotype that supports an intrinsic mechanism for amniotic band sequence. Am J Med Genet A 2005; 137A:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/15\">",
"      Streeter, GL. Focal deficiencies in fetal tissue and their relation to intrauterin amputations. Contrib Embryol Carnegie Inst 1930; 22:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/16\">",
"      Bamforth JS. Amniotic band sequence: Streeter's hypothesis reexamined. Am J Med Genet 1992; 44:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/17\">",
"      Daya M, Makakole M. Congenital vascular anomalies in amniotic band syndrome of the limbs. J Pediatr Surg 2011; 46:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/18\">",
"      Winer N, Salomon LJ, Essaoui M, et al. Pseudoamniotic band syndrome: a rare complication of monochorionic twins with fetofetal transfusion syndrome treated by laser coagulation. Am J Obstet Gynecol 2008; 198:393.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/19\">",
"      Rujiwetpongstorn J, Tongsong T. Amniotic band syndrome following septostomy in management of twin-twin transfusion syndrome: a case report. J Perinatol 2008; 28:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/20\">",
"      Lockwood C, Ghidini A, Romero R, Hobbins JC. Amniotic band syndrome: reevaluation of its pathogenesis. Am J Obstet Gynecol 1989; 160:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/21\">",
"      Bodamer OA, Popek EJ, Bacino C. Atypical presentation of amniotic band sequence. Am J Med Genet 2001; 100:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/22\">",
"      Donnai D, Winter RM. Disorganisation: a model for 'early amnion rupture'? J Med Genet 1989; 26:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/23\">",
"      O'Driscoll M, Peckham C, Kerr B. Four limb syndactyly, constriction rings and skin tags; amniotic bands or disorganization-like syndrome. Clin Dysmorphol 2008; 17:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/24\">",
"      Stanek J, de Courten-Myers G, Spaulding AG, et al. Case of complex craniofacial anomalies, bilateral nasal proboscides, palatal pituitary, upper limbs reduction, and amnion rupture sequence: disorganization phenotype? Pediatr Dev Pathol 2001; 4:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/25\">",
"      Hukki J, Balan P, Ceponiene R, et al. A case study of amnion rupture sequence with acalvaria, blindness, and clefting: clinical and psychological profiles. J Craniofac Surg 2004; 15:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/26\">",
"      Weinzweig N, Barr A. Radial, ulnar, and median nerve palsies caused by a congenital constriction band of the arm: single-stage correction. Plast Reconstr Surg 1994; 94:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/27\">",
"      ten Donkelaar HJ, Hamel BC, Hartman E, et al. Intestinal mucosa on top of a rudimentary occipital meningocele in amniotic rupture sequence: disorganization-like syndrome, homeotic transformation, abnormal surface encounter or endoectodermal adhesion? Clin Dysmorphol 2002; 11:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/28\">",
"      Burton DJ, Filly RA. Sonographic diagnosis of the amniotic band syndrome. AJR Am J Roentgenol 1991; 156:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/29\">",
"      Rohrbach M, Chitayat D, Drake J, et al. Prenatal diagnosis of fetal exencephaly associated with amniotic band sequence at 17 weeks of gestation by fetal magnetic resonance imaging. Fetal Diagn Ther 2007; 22:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/30\">",
"      Neuman J, Calvo-Garcia MA, Kline-Fath BM, et al. Prenatal imaging of amniotic band sequence: utility and role of fetal MRI as an adjunct to prenatal US. Pediatr Radiol 2012; 42:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/31\">",
"      Randel SB, Filly RA, Callen PW, et al. Amniotic sheets. Radiology 1988; 166:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/32\">",
"      Brown DL, Felker RE, Emerson DS. Intrauterine shelves in pregnancy: sonographic observations. AJR Am J Roentgenol 1989; 153:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/33\">",
"      Nelson LD, Grobman WA. Obstetric morbidity associated with amniotic sheets. Ultrasound Obstet Gynecol 2010; 36:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/34\">",
"      Tuuli MG, Shanks A, Bernhard L, et al. Uterine synechiae and pregnancy complications. Obstet Gynecol 2012; 119:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/35\">",
"      Tan KB, Tan TY, Tan JV, et al. The amniotic sheet: a truly benign condition? Ultrasound Obstet Gynecol 2005; 26:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/36\">",
"      Lopriore E, Lewi L, Oepkes D, et al. In utero acquired limb ischemia in monochorionic twins with and without twin-to-twin transfusion syndrome. Prenat Diagn 2008; 28:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/37\">",
"      Ronderos-Dumit D, Brice&ntilde;o F, Navarro H, Sanchez N. Endoscopic release of limb constriction rings in utero. Fetal Diagn Ther 2006; 21:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/38\">",
"      Quintero RA, Morales WJ, Phillips J, et al. In utero lysis of amniotic bands. Ultrasound Obstet Gynecol 1997; 10:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/39\">",
"      Sentilhes L, Verspyck E, Eurin D, et al. Favourable outcome of a tight constriction band secondary to amniotic band syndrome. Prenat Diagn 2004; 24:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/40\">",
"      Keswani SG, Johnson MP, Adzick NS, et al. In utero limb salvage: fetoscopic release of amniotic bands for threatened limb amputation. J Pediatr Surg 2003; 38:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/41\">",
"      Crombleholme TM, Dirkes K, Whitney TM, et al. Amniotic band syndrome in fetal lambs. I: Fetoscopic release and morphometric outcome. J Pediatr Surg 1995; 30:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/42\">",
"      Mart&iacute;nez-Fr&iacute;as ML, Bermejo E, Rodr&iacute;guez-Pinilla E. Body stalk defects, body wall defects, amniotic bands with and without body wall defects, and gastroschisis: comparative epidemiology. Am J Med Genet 2000; 92:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/43\">",
"      Froster UG, Baird PA. Amniotic band sequence and limb defects: data from a population-based study. Am J Med Genet 1993; 46:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/44\">",
"      H&uuml;sler MR, Wilson RD, Horii SC, et al. When is fetoscopic release of amniotic bands indicated? Review of outcome of cases treated in utero and selection criteria for fetal surgery. Prenat Diagn 2009; 29:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/45\">",
"      Levy R, Lacombe D, Rougier Y, Camus E. Limb body wall complex and amniotic band sequence in sibs. Am J Med Genet A 2007; 143A:2682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/46\">",
"      Lubinsky M, Sujansky E, Sanger W, et al. Familial amniotic bands. Am J Med Genet 1983; 14:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/47\">",
"      Luehr B, Lipsett J, Quinlivan JA. Limb-body wall complex: a case series. J Matern Fetal Neonatal Med 2002; 12:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/48\">",
"      Marras A, Dess&igrave; C, Macciotta A. Epidermolysis bullosa and amniotic bands. Am J Med Genet 1984; 19:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36902/abstract/49\">",
"      Young ID, Lindenbaum RH, Thompson EM, Pembrey ME. Amniotic bands in connective tissue disorders. Arch Dis Child 1985; 60:1061.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6764 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-1360C6F796-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36902=[""].join("\n");
var outline_f36_2_36902=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Early amniotic rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Vascular disruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetic mutation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PREGNANCY MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      RECURRENCE RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6764\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6764|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?20/40/21123\" title=\"diagnostic image 1\">",
"      Amniotic band sequence involving GI tract and a limb",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?1/47/1779\" title=\"diagnostic image 2A\">",
"      Amniotic bands",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?19/62/20448\" title=\"diagnostic image 2B\">",
"      Amniotic band sequence with cranial defect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?26/49/27409\" title=\"diagnostic image 2C\">",
"      Amniotic band sequence with abdominal wall defect",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/13/7386?source=related_link\">",
"      Genetic and environmental causes of birth defects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_2_36903="Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)";
var content_f36_2_36903=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36903/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36903/contributors\">",
"     Lawrence M Nelson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36903/contributors\">",
"     Vaishali Popat, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36903/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36903/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36903/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36903/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36903/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/2/36903/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 14, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary ovarian insufficiency (commonly referred to as premature ovarian failure) is defined as ovarian failure before age 40 years (which is two standard deviations below the age of normal menopause) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/1\">",
"     1",
"    </a>",
"    ]. The age specific incidence of spontaneous primary ovarian insufficiency is approximately 1 in 250 by age 35 and 1 in 100 by age 40 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/2\">",
"     2",
"    </a>",
"    ]. In its fully developed form, it is associated with amenorrhea, symptoms of estrogen deficiency, and gonadotropin levels in the menopausal range before age 40 years. The term \"failure\" means that ovarian function is not normal, but it does not necessarily imply total cessation of ovarian function. Patients who have been diagnosed with primary ovarian insufficiency may intermittently produce estrogen, ovulate, and in 5 to 10 percent of cases, conceive and have a normal pregnancy and delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the past, the diagnosis of primary ovarian insufficiency has required the development of associated amenorrhea. However, patients with this condition frequently have intermittent ovarian function and spontaneous menses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. This can occur even many years after the diagnosis. Therefore, the diagnostic criteria should not require amenorrhea, although abnormalities of menstrual function are always present. In a patient with an abnormal menstrual pattern over a three-month period in association with menopausal gonadotropin levels, it is reasonable to conclude that this patient has ovarian insufficiency, or spontaneous premature ovarian failure.",
"   </p>",
"   <p>",
"    The evaluation of women with spontaneous primary ovarian insufficiency will be reviewed here. Other issues related to primary ovarian insufficiency and to menopause are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=see_link\">",
"     \"Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1447?source=see_link\">",
"     \"Ovarian failure due to anticancer drugs and radiation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/26/23976?source=see_link\">",
"     \"Pathogenesis, diagnosis, and treatment of autoimmune ovarian failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/45/44761?source=see_link\">",
"     \"Clinical manifestations and diagnosis of menopause\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/22/15720?source=see_link\">",
"     \"Ovarian development and failure (menopause) in normal women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most women who develop spontaneous primary ovarian insufficiency (commonly referred to as premature ovarian failure) have experienced normal puberty and have established regular menses prior to the development of the condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/3\">",
"     3",
"    </a>",
"    ]. A disturbance in menstrual pattern is the most common presenting symptom, but there is no characteristic menstrual history that heralds the onset of spontaneous primary ovarian insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/6\">",
"     6",
"    </a>",
"    ]. Patients may develop amenorrhea acutely or experience a prolonged prodrome of oligomenorrhea or dysfunctional uterine bleeding.",
"   </p>",
"   <p>",
"    The disorder may first become apparent when menstruation fails to return after stopping the oral contraceptive or after a pregnancy. Relatively few women with this condition initially present with infertility. In a few cases, vasomotor symptoms, presumably related to relative estrogen deficiency, can precede the development of an abnormal menstrual pattern (or in women taking oral contraceptives vasomotor symptoms may appear during the placebo or pill-free part of the cycle) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/6\">",
"     6",
"    </a>",
"    ]. With progression to amenorrhea and profound estrogen deficiency, symptoms of atrophic vaginitis and dyspareunia become prominent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     IMPORTANCE OF EARLY DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the early diagnosis of primary ovarian insufficiency (premature ovarian failure) is important for osteoporosis prevention (and possibly prevention of later coronary heart disease), many women experience a significant delay in diagnosis (as long as a five-year delay in 25 percent of women) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/6\">",
"     6",
"    </a>",
"    ]. In addition, over 50 percent of young women with spontaneous primary ovarian insufficiency have reported seeing three or more clinicians before laboratory testing was finally done [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Young women who experience loss of menstrual regularity for three or more consecutive months deserve appropriate evaluation at their first visit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/7\">",
"     7",
"    </a>",
"    ]. The presence of regular and predictable menstrual cycles is an indication that the hypothalamic-pituitary-ovarian axis is functioning properly. Loss of menstrual regularity may be a sign of ovarian insufficiency, and the associated estrogen deficiency. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/63/37880?source=see_link&amp;anchor=H5#H5\">",
"     \"Management of spontaneous primary ovarian insufficiency (premature ovarian failure)\", section on 'Estrogen deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Bone mineral density",
"    </span>",
"    &nbsp;&mdash;&nbsp;Loss of menstrual regularity may be a sign of ovarian insufficiency, and the associated estrogen deficiency is a well-established risk factor for osteoporosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. One study showed that approximately two-thirds of young women with primary ovarian insufficiency have a femoral neck bone mineral density more than one standard deviation below the mean of a reference group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/11\">",
"     11",
"    </a>",
"    ]. Delay in diagnosis probably plays an important role in the development of low bone density [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/6\">",
"     6",
"    </a>",
"    ]. Once the diagnosis of primary ovarian insufficiency has been made, bone mineral density should be measured using DXA. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42583?source=see_link\">",
"     \"Overview of dual-energy x-ray absorptiometry\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A detailed history should address the following issues to determine a potential cause of ovarian failure (",
"    <a class=\"graphic graphic_table graphicRef74029 \" href=\"mobipreview.htm?43/47/44795\">",
"     table 1",
"    </a>",
"    ). However, in 90 percent of cases the cause of spontaneous primary ovarian insufficiency (premature ovarian failure) is unknown. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=see_link\">",
"     \"Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"    </a>",
"    .) Important historical features of primary ovarian insufficiency include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms of estrogen deficiency such as vasomotor symptoms and vaginal dryness are common. However, because intermittent ovarian function occurs in approximately 50 percent of women with spontaneous primary ovarian insufficiency [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/4\">",
"       4",
"      </a>",
"      ], the absence of vasomotor symptoms or vaginal dryness should not dissuade one from considering the diagnosis.",
"     </li>",
"     <li>",
"      Prior ovarian surgery, chemotherapy, or radiation therapy, as these all damage ovarian tissue. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1447?source=see_link\">",
"       \"Ovarian failure due to anticancer drugs and radiation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Autoimmune diseases, such as polyglandular failure, hypothyroidism, Addison disease, vitiligo, myasthenia gravis, Graves' disease, Sj&ouml;gren&rsquo;s syndrome, lupus, hypoparathyroidism, recurrent mucocutaneous candidiasis, celiac disease, type 1 diabetes, or rheumatoid arthritis in themselves or in their family. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/26/23976?source=see_link\">",
"       \"Pathogenesis, diagnosis, and treatment of autoimmune ovarian failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Approximately 3 percent of women with spontaneous primary ovarian insufficiency develop adrenal insufficiency, a 300-fold increase compared with the general population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/12\">",
"       12",
"      </a>",
"      ]. Symptoms could include anorexia, weight loss, vague abdominal pain, weakness, fatigue, salt craving, or increased skin pigmentation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33800?source=see_link\">",
"       \"Clinical manifestations of adrenal insufficiency in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9896?source=see_link\">",
"       \"Pathogenesis of autoimmune adrenal insufficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A family history of primary ovarian insufficiency because approximately 10 percent of cases of ovarian failure are familial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A family history of fragile X syndrome, mental retardation, developmental delay, intension tremor, ataxia, or dementia because approximately 6 percent of cases of ovarian failure are associated with premutations in the FMR1 gene (the gene responsible for the fragile X syndrome and the fragile X-related",
"      <span class=\"nowrap\">",
"       tremor/ataxia",
"      </span>",
"      syndrome) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=see_link&amp;anchor=H4#H4\">",
"       \"Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)\", section on 'Fragile X syndrome premutation carriers'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23399?source=see_link&amp;anchor=H8#H8\">",
"       \"Prenatal screening and diagnosis for fragile X syndrome\", section on 'Premutation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Association with deafness because familial autosomal recessive primary ovarian insufficiency may be associated with deafness (Perrault Syndrome) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Risk factors for osteoporosis in addition to the ovarian failure. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link\">",
"       \"Osteoporotic fracture risk assessment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most women who develop primary ovarian insufficiency (premature ovarian failure) after experiencing normal pubertal development and menarche have no abnormalities on physical examination, but occasionally the following may be found:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Features of Turner syndrome, including: short stature, low posterior hairline, high arched palate, shield chest with widely spaced nipples, a wide carrying angle, and short fourth and fifth metacarpals, even when the diagnosis was not previously suspected. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ptosis, which has been associated with a rare familial form of primary ovarian insufficiency [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Goiter, consistent with Hashimoto's thyroiditis or Graves' disease.",
"     </li>",
"     <li>",
"      Increased skin pigmentation, consistent with Addison disease. In this case orthostatic hypotension may also be present.",
"     </li>",
"     <li>",
"      Signs of atrophic vaginitis may be seen, although normal vaginal examination including normal cervical mucus and vaginal maturation index may also be seen, if there has been recent ovarian function [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/3-5\">",
"       3-5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ovarian enlargement due to lymphocytic oophoritis or a steroidogenic enzyme defect [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/19,20\">",
"       19,20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests that should be done to evaluate a woman for the possibility of primary ovarian insufficiency (premature ovarian failure) include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A pregnancy test, which should be performed in any woman of childbearing age who has missed menses.",
"     </li>",
"     <li>",
"      Serum prolactin concentration, to determine if hyperprolactinemia is the cause of the symptoms.",
"     </li>",
"     <li>",
"      Serum concentration of FSH, to determine if she is hypergonadotropic, and estradiol (to rule out an isolated mid-cycle gonadotropic surge). It is our experience that low estradiol, especially depending on the assay, is not nearly as reliable as the FSH evaluation to identify primary ovarian insufficiency.",
"     </li>",
"     <li>",
"      The progestin-withdrawal test is no substitute for laboratory evaluation as this procedure can be falsely reassuring and lead to a delay in diagnosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Women younger than 40 years who have had three months of amenorrhea, oligomenorrhea, or dysfunctional uterine bleeding in association with FSH levels in the menopausal range (defined by the assay method employed) meet diagnostic criteria for primary ovarian insufficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     OTHER EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis of primary ovarian insufficiency (premature ovarian failure) is made, other evaluation should include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Autoimmune disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young women with spontaneous primary ovarian insufficiency are at increased risk of developing autoimmune adrenal insufficiency, a potentially fatal disorder. Generally, the development of disordered menses associated with primary ovarian insufficiency precedes the development of symptomatic adrenal insufficiency by several years.",
"   </p>",
"   <p>",
"    If proper screening is performed, approximately 3 percent of women with spontaneous primary ovarian insufficiency will be found to have asymptomatic autoimmune adrenal insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/12\">",
"     12",
"    </a>",
"    ]. As a screen for the presence of asymptomatic autoimmune adrenal insufficiency, serum anti-adrenal and anti-21 hydroxylase antibodies should be measured at the time of diagnosis of spontaneous primary ovarian insufficiency in all women.",
"   </p>",
"   <p>",
"    Those with positive antibodies should be carefully evaluated for the presence of adrenal insufficiency. Even if their adrenal function is found to be normal at their initial evaluation, women with positive adrenal antibodies are at increased risk of developing adrenal insufficiency in the future and should be followed carefully to detect this eventuality early. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/0/40969?source=see_link\">",
"     \"Causes of primary adrenal insufficiency (Addison's disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serum TSH, T4, and anti-thyroid-peroxidase antibodies, because of the association of hypothyroidism with spontaneous primary ovarian insufficiency [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Assessment of bone mineral density with DXA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=see_link\">",
"       \"Epidemiology and etiology of premenopausal osteoporosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42583?source=see_link\">",
"       \"Overview of dual-energy x-ray absorptiometry\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The predictive value of a commercially available serum ovarian autoantibody test is poor as a method to identify women with autoimmune primary ovarian insufficiency (an indirect immunofluorescence assay using cynomolgus monkey ovary). As an example, in a study of 26 women with 46,XX spontaneous primary ovarian insufficiency and 26 normal cycling women, 50 percent (13 of 26) of women with ovarian failure and 31 percent (8 of 26) of normal women had ovarian antibodies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Karyotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;A karyotype should be performed as part of the basic evaluation for all patients with primary ovarian insufficiency, with or without stigmata of Turner syndrome. Overall, however, in patients who have experienced normal puberty before developing primary ovarian insufficiency, an abnormal karyotype will explain the abnormality in a low percentage of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/3\">",
"     3",
"    </a>",
"    ]. Neither age nor parity rules out a chromosomal abnormality. Women with X chromosome abnormalities have delivered normal children and subsequently developed primary ovarian insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/23\">",
"     23",
"    </a>",
"    ]. Identification of a chromosomal abnormality also alters management. Women with Turner syndrome should be screened for associated abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although rare in women with spontaneous primary ovarian insufficiency, those with Y chromosome material present require oophorectomy because of the risk of gonadal tumors in women with Y chromosome-containing gonadal tissue. Molecular genetic techniques to identify the critical Y chromosome components have been developed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     FMR1 premutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A growing body of literature demonstrates an association between primary ovarian insufficiency and premutations for the fragile X syndrome (the FMR1 gene) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/26\">",
"     26",
"    </a>",
"    ]. Fragile X syndrome is an X-linked form of mental retardation that is one of the most common causes of mental retardation worldwide. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)\", section on 'Fragile X syndrome premutation carriers'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23399?source=see_link&amp;anchor=H8#H8\">",
"     \"Prenatal screening and diagnosis for fragile X syndrome\", section on 'Premutation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although early menopause occurs in less than one-third of patients with premutations, the remainder exhibit hormonal changes of early ovarian aging while still experiencing regular menstrual cycles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women with the FMR1 premutation are at risk of having a child with mental retardation. With familial primary ovarian insufficiency, the prevalence of premutations in the FMR1 gene is approximately 14 percent. In sporadic cases of primary ovarian insufficiency the prevalence of the premutation is approximately 2 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American College of Obstetrics and Gynecology now recommends that women with primary ovarian insufficiency or an elevated FSH level before age 40 years without known cause be screened for FMR1 premutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to primary ovarian insufficiency, premutation carriers can present with fragile X associated tremor-ataxia syndrome (FXTAS) or mild cognitive and behavioral deficits on the spectrum of those seen in fragile X syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/35/29242?source=see_link&amp;anchor=H18#H18\">",
"     \"The spinocerebellar ataxias\", section on 'Fragile X-associated tremor/ataxia syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23399?source=see_link&amp;anchor=H8#H8\">",
"     \"Prenatal screening and diagnosis for fragile X syndrome\", section on 'Premutation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pelvic ultrasound examination of the ovaries and ovarian biopsy has no proven clinical benefit in managing primary ovarian insufficiency. As an example, ovarian biopsy is known to be inaccurate because of sampling error, and pregnancy has been reported in women in whom an open wedge biopsy showed no follicles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/3,31\">",
"       3,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Measurement of serum concentration of progesterone, if there is associated primary amenorrhea, failure of pubertal development, and high FSH, to evaluate the possibility of 17 hydroxylase or 17-20 desmolase deficiencies. In these cases serum concentrations of progesterone will be elevated [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36903/abstract/20,32\">",
"       20,32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/5/19538?source=see_link\">",
"       \"Patient information: Early menopause (primary ovarian insufficiency) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/63/12276?source=see_link\">",
"       \"Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous primary ovarian insufficiency (commonly referred to as premature ovarian failure) is one of many causes that may be found when evaluating a woman for amenorrhea or oligomenorrhea. Diagnosis is important in order to explain to the patient the variable natural history of the condition, to look for associated diseases, and, most importantly, to treat the hypogonadism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dr. Nelson's work was supported by the Intramural Research Program on Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/1\">",
"      Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/2\">",
"      van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999; 5:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/3\">",
"      Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/4\">",
"      Nelson LM, Anasti JN, Kimzey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994; 79:1470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/5\">",
"      Taylor AE, Adams JM, Mulder JE, et al. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 1996; 81:3615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/6\">",
"      Alzubaidi NH, Chapin HL, Vanderhoof VH, et al. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol 2002; 99:720.",
"     </a>",
"    </li>",
"    <li>",
"     Mishell, DRJ, Stenchever, MA, Droegemueller, W, Herbst, AL. Primary and Secondary Amenorrhea. Comprehensive Gynecology. St. Louis: Mosby, 1997: 1043.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/8\">",
"      Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with amenorrhoea. BMJ 1990; 301:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/9\">",
"      NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/10\">",
"      Pouill&egrave;s JM, Tr&eacute;molli&egrave;res F, Bonneu M, Ribot C. Influence of early age at menopause on vertebral bone mass. J Bone Miner Res 1994; 9:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/11\">",
"      Anasti JN, Kalantaridou SN, Kimzey LM, et al. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1998; 91:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/12\">",
"      Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002; 17:2096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/13\">",
"      van Kasteren YM, Hundscheid RD, Smits AP, et al. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod 1999; 14:2455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/14\">",
"      Marozzi A, Vegetti W, Manfredini E, et al. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 2000; 15:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/15\">",
"      Hagerman RJ, Leavitt BR, Farzin F, et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 2004; 74:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/16\">",
"      Nishi Y, Hamamoto K, Kajiyama M, Kawamura I. The Perrault syndrome: clinical report and review. Am J Med Genet 1988; 31:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/17\">",
"      Meyers CM, Boughman JA, Rivas M, et al. Gonadal (ovarian) dysgenesis in 46,XX individuals: frequency of the autosomal recessive form. Am J Med Genet 1996; 63:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/18\">",
"      Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001; 27:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/19\">",
"      Biscotti CV, Hart WR, Lucas JG. Cystic ovarian enlargement resulting from autoimmune oophoritis. Obstet Gynecol 1989; 74:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/20\">",
"      Larrea F, Lisker R, Ba&ntilde;uelos R, et al. Hypergonadotrophic hypogonadism in an XX female subject due to 17,20 steroid desmolase deficiency. Acta Endocrinol (Copenh) 1983; 103:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/21\">",
"      Kim TJ, Anasti JN, Flack MR, et al. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1997; 89:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/22\">",
"      Novosad JA, Kalantaridou SN, Tong ZB, Nelson LM. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health 2003; 3:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/23\">",
"      Krauss CM, Turksoy RN, Atkins L, et al. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 1987; 317:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/24\">",
"      Gemmill RM, Pearce-Birge L, Bixenman H, et al. Y chromosome--specific DNA sequences in Turner-syndrome mosaicism. Am J Hum Genet 1987; 41:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/25\">",
"      Tho SP, McDonough PG. Use of Y DNA probes to identify children at risk for dysgenetic gonadal tumors. Clin Obstet Gynecol 1987; 30:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/26\">",
"      Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 premutation and reproduction. Fertil Steril 2007; 87:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/27\">",
"      Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004; 89:4569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/28\">",
"      Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000; 97:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/29\">",
"      Conway GS, Hettiarachchi S, Murray A, Jacobs PA. Fragile X premutations in familial premature ovarian failure. Lancet 1995; 346:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/30\">",
"      American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol 2006; 107:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/31\">",
"      Khastgir G, Abdalla H, Studd JW. The case against ovarian biopsy for the diagnosis of premature menopause. Br J Obstet Gynaecol 1994; 101:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36903/abstract/32\">",
"      Pellicer A, Mir&oacute; F, Sampaio M, et al. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency. Fertil Steril 1991; 55:970.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7443 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-125.39.66.150-851E2265C2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36903=[""].join("\n");
var outline_f36_2_36903=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      IMPORTANCE OF EARLY DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Bone mineral density",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      OTHER EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Autoimmune disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Karyotype",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      FMR1 premutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7443\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7443|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/47/44795\" title=\"table 1\">",
"      Major causes of primary ovarian insufficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/0/40969?source=related_link\">",
"      Causes of primary adrenal insufficiency (Addison's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=related_link\">",
"      Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/45/44761?source=related_link\">",
"      Clinical manifestations and diagnosis of menopause",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33800?source=related_link\">",
"      Clinical manifestations of adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=related_link\">",
"      Epidemiology and etiology of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/63/37880?source=related_link\">",
"      Management of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=related_link\">",
"      Osteoporotic fracture risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/22/15720?source=related_link\">",
"      Ovarian development and failure (menopause) in normal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1447?source=related_link\">",
"      Ovarian failure due to anticancer drugs and radiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42583?source=related_link\">",
"      Overview of dual-energy x-ray absorptiometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=related_link\">",
"      Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9896?source=related_link\">",
"      Pathogenesis of autoimmune adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/26/23976?source=related_link\">",
"      Pathogenesis, diagnosis, and treatment of autoimmune ovarian failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/63/12276?source=related_link\">",
"      Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/5/19538?source=related_link\">",
"      Patient information: Early menopause (primary ovarian insufficiency) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23399?source=related_link\">",
"      Prenatal screening and diagnosis for fragile X syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/35/29242?source=related_link\">",
"      The spinocerebellar ataxias",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_2_36904="Stage IV PBC - low power";
var content_f36_2_36904=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61497&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61497&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stage IV PBC (low power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is a noncaseating granuloma next to a central vein. This wedge section was taken from a cirrhotic liver at the time of an end-to-side portacaval shunt surgery that was done to treat uncontrollable hemorrhage from esophageal varices.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36904=[""].join("\n");
var outline_f36_2_36904=null;
var title_f36_2_36905="Chapter 3B: Primacy of sodium transport in proximal function";
var content_f36_2_36905=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 3B: Primacy of sodium transport in proximal function",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36905/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36905/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36905/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36905/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36905/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/2/36905/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/2/36905/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/2/36905/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 1, 2009.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between the proximal reabsorption of sodium and that of many other filtered solutes is often important clinically. This is particularly true in hypovolemic states in which the increase in proximal Na+ transport is associated with a parallel rise in the reabsorption of bicarbonate, urea, calcium, and uric acid. The remainder of this chapter will review the different transport systems for these solutes (both in the proximal tubule and in other nephron segments) and the potential clinical relevance of their relationship to Na+ reabsorption. In many cases, the changes that occur are at the expense of the homeostatic requirements for these solutes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BICARBONATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 80 percent of the filtered HCO3- is reabsorbed in the proximal tubule and the remainder in the distal tubule and collecting tubules. HCO3- reabsorption is accomplished by the active transport of H+ from the cell into the lumen; this process is mediated primarily by the Na+-H+ antiporter in the proximal tubule and by a H+-ATPase pump in the distal nephron (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12762?source=see_link\">",
"     \"Chapter 11A: Renal hydrogen excretion\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Relation of TmHCO3- to sodium transport",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term TmHCO3- refers &nbsp;to the maximum tubular reabsorptive capacity for HCO3- per unit time. To measure this parameter, NaHCO3 is infused intravenously to raise the plasma HCO3- concentration and, therefore, the filtered load. Tubular reabsorption, measured in milliequivalents of HCO3- reabsorbed per minute, can then be calculated from",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Tubular reabsorption &nbsp; &nbsp;= &nbsp; filtered load &nbsp;- &nbsp;urinary excretion",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;= &nbsp; Cin &nbsp;x &nbsp;plasma [HCO3- ] &nbsp;- &nbsp;urine [HCO3-] &nbsp;x &nbsp;volume",
"   </p>",
"   <p>",
"    The results of such an experiment are illustrated in figure 1 (",
"    <a class=\"graphic graphic_figure graphicRef71017 \" href=\"mobipreview.htm?42/61/43997\">",
"     figure 1",
"    </a>",
"    ). There appears to be a maximum HCO3- reabsorption of 26 to 28",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    of glomerular filtrate&dagger;. This would be an appropriate mechanism by which the kidney prevents the plasma HCO3- concentration from exceeding the normal value of 22 to 26",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    since the extra HCO3- would be excreted in the urine. However, the proximal reabsorption of HCO3- is linked (by the Na+-H+ antiporter) to Na+ transport, and the infusion of NaHCO3 expands the extracellular volume, a stimulus known to diminish proximal Na+ and perhaps HCO3- reabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Figure 2 (",
"    <a class=\"graphic graphic_figure graphicRef80338 \" href=\"mobipreview.htm?25/50/26413\">",
"     figure 2",
"    </a>",
"    ) depicts the results of two HCO3- titration experiments in a patient with moderate renal failure. When NaHCO3-induced volume expansion was allowed to occur, HCO3- reabsorption reached a plateau when the plasma HCO3- concentration was 28",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    In comparison, when volume expansion was minimized by prior volume depletion, HCO3- reabsorption continued to rise even when the plasma HCO3- concentration reached 36",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    In the rat, a TmHCO3- &nbsp;cannot be demonstrated if hypervolemia is prevented, even if the plasma HCO3- concentration is greater than 60",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;&dagger; Since the TmHCO3- is measured in meq reabsorbed per minute, the maximum reabsorption of 28",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    of glomerular filtrate must be corrected for the GFR. If the GFR were 125",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    (or 0.125",
"    <span class=\"nowrap\">",
"     L/min),",
"    </span>",
"    then the TmHCO3- would be 3.5",
"    <span class=\"nowrap\">",
"     meq/min",
"    </span>",
"    (28",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    &nbsp; x &nbsp; 0.125",
"    <span class=\"nowrap\">",
"     L/min).",
"    </span>",
"   </p>",
"   <p>",
"    These observations demonstrate that there is no absolute Tm for HCO3-, since the reabsorptive capacity varies directly with the fractional reabsorption of Na+ [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. This assumes clinical importance in patients with volume depletion and metabolic alkalosis (high plasma HCO3- concentration, elevated arterial pH). The normal response to an increase in the plasma HCO3- concentration is to excrete the excess HCO3- in the urine. However, hypovolemia and the associated hypochloremia enhance HCO3- reabsorption, resulting in the retention of the excess HCO3- and perpetuation of the alkalosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/28/10692?source=see_link\">",
"     \"Pathogenesis of metabolic alkalosis\"",
"    </a>",
"    .) HCO3- excretion will rise only if the stimulus to Na+ and Cl- retention is removed by the restoration of normovolemia.",
"   </p>",
"   <p>",
"    The principal Na+-bicarbonate cotransporter in the kidney, NBC-1A, is a member of the NBC (",
"    <strong>",
"     N",
"    </strong>",
"    a+-",
"    <strong>",
"     B",
"    </strong>",
"    icarbonate",
"    <strong>",
"     C",
"    </strong>",
"    otransporter) family of proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/4\">",
"     4",
"    </a>",
"    ]. NBC-1A is derived from a gene that can give rise to at least three spliced isoforms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/5\">",
"     5",
"    </a>",
"    ]; they principally differ in tissue distribution, with NBC-1A being kidney specific.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Glucose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Under normal conditions, all the filtered glucose is reabsorbed in the proximal tubule and returned to the systemic circulation via the peritubular capillaries. This process occurs in two steps. Filtered glucose enters the cell by passive cotransport with Na+ (even though glucose moves uphill against a concentration gradient) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]; it then leaves the cell at the basolateral membrane, probably by diffusion via specific glucose transporters that are Na+-independent and that are limited to the basolateral membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Na+-glucose cotransporters have different characteristics in the different proximal segments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/7\">",
"     7",
"    </a>",
"    ]. The S1 and S2 segments have a high-capacity, low-affinity carrier that is able to remove most of the filtered glucose. (This glucose is largely returned to the systemic circulation, since these segments do not primarily use glucose for oxidative metabolism) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The high degree of early proximal reabsorption results in relatively little glucose being delivered to the S3 segment. To reabsorb the remaining glucose, the carrier at this site has a higher affinity and a 2:1 binding ratio, i.e., 2 Na+: 1 glucose. Thus, the additive effect of the favorable inward gradient of two Na+ ions is used to drive the uphill transport of glucose against an increasing concentration gradient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/6\">",
"     6",
"    </a>",
"    ]. Similar differences are present in the glucose transporters in the basolateral membrane that return reabsorbed glucose to the systemic circulation: low-affinity in the S1 segment; and high-affinity in the later parts of the proximal tubule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cDNAs for the high-capacity, low-affinity carrier, termed SGLT2, and the low-capacity high-affinity carrier, termed SGLT1, have both been cloned and sequenced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Both transporters are highly homologous at the amino acid level, and are able to transport sodium and glucose via transmembrane pores. SGLT2 is exclusively found in the proximal tubule, while SGLT1 is also expressed in the gastrointestinal tract.",
"   </p>",
"   <p>",
"    Studies in normovolemic subjects &nbsp;have shown a Tm for glucose of approximately 375",
"    <span class=\"nowrap\">",
"     mg/min",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef58196 \" href=\"mobipreview.htm?37/30/38381\">",
"     figure 3",
"    </a>",
"    ). Thus, glucose should not appear in the urine until the filtered load exceeds this value. If the GFR is 125",
"    <span class=\"nowrap\">",
"     mL/min,",
"    </span>",
"    glucosuria should not begin until the plasma glucose concentration is greater than 300",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [125",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    &nbsp; x &nbsp; 3",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    (or 300",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    equals 375",
"    <span class=\"nowrap\">",
"     mg/min].",
"    </span>",
"    (The normal plasma glucose concentration is 60 to 100",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    fasting.)",
"   </p>",
"   <p>",
"    However, glucose can usually be detected in the urine when the plasma glucose concentration exceeds 180 to 200",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    This deviation from the Tm is called splay and has been ascribed to heterogeneity in the relationship between glomerular size and proximal tubular length within individual nephrons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/13\">",
"     13",
"    </a>",
"    ]. A nephron with a large glomerulus, i.e., high filtered load, or a relatively short proximal tubule, i.e., low reabsorptive capacity, will spill glucose in the urine at a lower plasma glucose concentration than predicted from the Tm for the whole kidney.",
"   </p>",
"   <p>",
"    Clinically, glucosuria is most commonly seen when the filtered load is increased due to hyperglycemia in uncontrolled diabetes mellitus. Less often, there is a defect in proximal reabsorption that may be selective as in renal glucosuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/14\">",
"     14",
"    </a>",
"    ], or part of a generalized abnormality in proximal transport as in the Fanconi syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/15\">",
"     15",
"    </a>",
"    ]. In renal glucosuria, the appearance of glucose in the urine at a normal plasma glucose concentration is thought to be due either to a decreased number of glucose carriers or to a reduction in the affinity of the carriers for glucose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Urea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urea, which is an end-product of protein metabolism, is lipid-soluble and able to cross most cell membranes by passive diffusion. The reabsorption of water in the proximal tubule increases the tubular fluid urea concentration, thereby allowing urea to be reabsorbed passively down a concentration gradient. This may be facilitated by a constitutive transporter. Urea also is reabsorbed in the more distal nephron segments, the importance of which will be discussed in Chap. 4. The net effect is that only 50 to 60 percent of the filtered urea is normally excreted.",
"   </p>",
"   <p>",
"    The urea concentration in the blood is measured as the blood urea nitrogen (BUN). The BUN tends to vary inversely with the GFR, a reflection of the importance of glomerular filtration in urea excretion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/55/21368?source=see_link\">",
"     \"Chapter 2E: Clinical evaluation of the renal circulation\"",
"    </a>",
"    .) Thus, an elevation in the BUN is often due to a fall in GFR. There are, however, two important exceptions: conditions associated with enhanced urea production, such as gastrointestinal bleeding, corticosteroid therapy, or a high-protein diet; and volume depletion, in which the increase in proximal Na+ and H2O reabsorption results in enhanced urea reabsorption and consequently a rise in the BUN. This is referred to as prerenal azotemia, since the elevation in BUN is not due to renal disease and is associated with no or a lesser elevation in the plasma creatinine concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CALCIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary Na+, K+, and Cl- are almost completely absorbed in the gastrointestinal tract, and their steady-state concentrations in the extracellular fluid are maintained primarily by changes in urinary excretion. In contrast, calcium and phosphate absorption are incomplete, and variations in intestinal absorption and calcium phosphate release from bone, as well as in urinary excretion, contribute to the regulation of calcium and phosphate balance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2631?source=see_link\">",
"     \"Chapter 6F: Hormonal regulation of calcium and phosphate balance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 40 percent of the plasma Ca2+ is bound to albumin and is not filtered at the glomerulus. Of the remaining 60 percent, 50 percent exists as the physiologically important ionic (free) Ca2+, and 10 percent is bound to citrate, bicarbonate, or phosphate. The filtered Ca2+ is reabsorbed throughout the nephron, with about 5 percent being excreted on a regular diet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/18\">",
"     18",
"    </a>",
"    ]. Approximately 80 to 85 percent of the filtered Ca2+ is reabsorbed in the proximal tubule and medullary loop of Henle; most, but not all, of this transport is passive, following gradients established by NaCl and water reabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Passive calcium reabsorption in the thick ascending limb occurs via the paracellular pathway, a process that appears to be facilitated by a tight junction protein called paracellin-1 or claudin 16 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The regulation of Ca2+ excretion according to physiologic needs appears to occur primarily in the cortical distal nephron, including the distal tubule and the adjacent cortical thick ascending limb of the loop of Henle and the connecting segment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/19,21,23\">",
"     19,21,23",
"    </a>",
"    ]. In these segments, parathyroid hormone (PTH) and to a lesser degree vitamin D stimulate Ca2+ reabsorption. PTH activates a hormone-specific adenylate cyclase system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/23-28\">",
"     23-28",
"    </a>",
"    ] while vitamin D induces the production of calcium-binding proteins (calbindins) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/29\">",
"     29",
"    </a>",
"    ] and by enhancing the effect of PTH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Luminal Ca2+ appears to enter the cells through Ca2+ channels in the apical membrane, down a favorable electrochemical gradient (cell interior negative, low cell Ca2+ concentration of less than 200",
"    <span class=\"nowrap\">",
"     nanomol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/25,27\">",
"     25,27",
"    </a>",
"    ]. PTH increases Ca2+ entry, although the mechanism by which this occurs is incompletely understood. It has been suggested that the primary effect of PTH is to increase the number of open Cl- channels in the basolateral membrane; the ensuing loss of anionic chloride from the cell will hyperpolarize the cell membrane, thereby enhancing both the activity of the voltage-dependent Ca2+ channels in the luminal membrane and the gradient for passive Ca2+ entry into the cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/23,27\">",
"     23,27",
"    </a>",
"    ]. A vitamin D-dependent calcium-binding protein also appears to facilitate Ca2+ uptake at the luminal membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extrusion of this Ca2+ into the peritubular interstitium may then occur at least in part via a basolateral Ca2+-ATPase pump or a 3Na+-1Ca2+ exchanger [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/19,25,31\">",
"     19,25,31",
"    </a>",
"    ]. The latter transporter, which may be responsible for up to 70 percent of &nbsp;calcium extrusion, uses the favorable inward electrochemical gradient for Na+ entry (in this setting occurring at the basolateral membrane) to drive the reabsorption of Ca2+ [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/24,31\">",
"     24,31",
"    </a>",
"    ]. In addition to increasing the number of open Cl- channels in the basolateral membrane, PTH may also increase the number of Na+-Ca2+ exchangers, thereby enhancing Ca2+ extrusion from the cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical implications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interaction between these humoral factors can be illustrated by the response to an increase in dietary calcium intake. The ensuing rise in Ca2+ absorption from the gut leads to a small elevation in the plasma Ca2+ concentration, which diminishes the release of both PTH and calcitriol (1,25-dihydroxycholecalciferol, the most active form of vitamin D). The net effect is reduced distal Ca2+ reabsorption and excretion of the excess Ca2+.",
"   </p>",
"   <p>",
"    The thick ascending limb also may contribute to the calciuric response after a calcium load. This effect appears to be mediated by the calcium-sensing receptor, which is expressed on the basolateral membrane of these cells (see Magnesium below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, a reduction in the plasma Ca2+ concentration below 8.5 to 9",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (the lower limit of normal) usually results in a fall in urinary Ca2+ excretion to very low levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/35\">",
"     35",
"    </a>",
"    ]. This response is mediated in part by hypocalcemia-induced stimulation of PTH and calcitriol secretion.",
"   </p>",
"   <p>",
"    Let us now consider how these relationships are altered in patients with hypoparathyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/35\">",
"     35",
"    </a>",
"    ]. Since PTH is the major stimulus to calcitriol synthesis, there is a deficiency of both hormones in this disorder. As a result, the relationship between the plasma Ca2+ concentration and urinary Ca2+ excretion is reset: the impairment in Ca2+ reabsorption leads to persistent calciuria even though the patient may have a plasma Ca2+ concentration below 7.5",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    If calcitriol is now given to correct the hypocalcemia, there will still be PTH deficiency and a persistent defect in distal Ca2+ transport. Consequently, an elevation in the plasma Ca2+ concentration to a still low level of 8",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    may be associated with a significant rise in urinary Ca2+ excretion. Any attempt at further correction of the hypocalcemia will lead to increasing hypercalciuria and possible calcium stone formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Thus, the development of hypercalciuria often limits the degree to which the plasma Ca2+ concentration can be normalized.",
"   </p>",
"   <p>",
"    The passive reabsorption of most of the filtered Ca2+ in the proximal tubule and loop of Henle also is important clinically, since it means that Ca2+ transport in these segments will be affected by changes in net NaCl transport. Thus, on a constant Ca2+ intake, variations in Na+ reabsorption (due to diet, drugs, or changes in the effective circulating volume) will alter both Na+ and Ca2+ excretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These characteristics are useful in the therapy of hypercalcemia and of nephrolithiasis due to hypercalciuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/18,37\">",
"     18,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypercalcemia can be corrected by increasing Ca2+ excretion. This can be achieved by decreasing Na+ reabsorption in the proximal tubule with a high NaCl intake, and in the loop of Henle by the use of a diuretic which inhibits loop NaCl reabsorption, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Conversely, lowering calcium excretion may reduce the frequency of stone formation in patients with idiopathic hypercalciuria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/38\">",
"       38",
"      </a>",
"      ]. This can be achieved by increasing Na+ and, secondarily, Ca2+ reabsorption in the proximal tubule and loop of Henle by inducing volume depletion with a low Na+ intake and a diuretic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/37-39\">",
"       37-39",
"      </a>",
"      ]. However, the diuretic must act distal to the medullary thick ascending limb so that it can enhance the excretion of Na+ without also increasing that of Ca2+. Both the thiazide diuretics, which act in the distal tubule, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/12/38085?source=see_link\">",
"       amiloride",
"      </a>",
"      , which acts in the connecting segment, are useful in this regard.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to inducing volume depletion, these agents also lower Ca2+ excretion by directly stimulating distal Ca2+ reabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. How this occurs is not well understood; it is likely to be indirect, since the two diuretics act by different mechanisms. One theory proposes a central role for enhanced Ca2+ uptake at the luminal membrane via a mechanism similar to that noted above for parathyroid hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. According to this hypothesis, a diuretic-induced reduction in Cl- entry across the luminal membrane combined with continued Cl- exit through Cl- channels in the basolateral membrane results in hyperpolarization of the cell (",
"    <a class=\"graphic graphic_figure graphicRef64975 \" href=\"mobipreview.htm?36/27/37309\">",
"     figure 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/41\">",
"     41",
"    </a>",
"    ]. The net effect is increased activity of the voltage-dependent luminal Ca2+ channels and an enhanced electrical gradient favoring Ca2+ uptake from the lumen.",
"   </p>",
"   <p>",
"    The fall in the cell Na+ concentration following diuretic-induced inhibition of Na+ uptake also may play a contributory role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/25,33\">",
"     25,33",
"    </a>",
"    ]. This intracellular change will enhance the gradient for passive Na+ entry across the basolateral membrane and therefore for Ca2+ extrusion from the cell via the basolateral Na+-Ca2+ exchanger.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PHOSPHATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eighty to ninety-five percent of the filtered phosphate is normally reabsorbed, almost all of this occurring in the proximal tubule. Filtered phosphate initially moves from the lumen into the cell via specific Na+-phosphate cotransporters in the luminal membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. These transporters generally have a 3Na+:1HPO42- &nbsp;stoichiometry; this allows the favorable inward gradient of three Na+ ions to drive continued phosphate uptake despite a falling tubular fluid phosphate concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/46\">",
"     46",
"    </a>",
"    ]. High affinity transporters in the late proximal tubule also contribute to the ability to reabsorb most of the filtered phosphate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/47\">",
"     47",
"    </a>",
"    ]. The phosphate that enters the cell then diffuses passively out across the basolateral membrane via an uncertain mechanism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are three families of Na+-phosphate cotransporters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/5,43,48\">",
"     5,43,48",
"    </a>",
"    ]. Type IIa appears to be the most important Na+-phosphate cotransporter within the proximal tubule as evidenced by severe renal phosphate wasting in mice with targeted inactivation of this protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/5,49\">",
"     5,49",
"    </a>",
"    ]. Expression in the proximal tubule of isoforms of the type IIa cotransporter may regulate the functional receptor via a dominant negative effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Proximal phosphate transport is primarily regulated by two factors, both of which specifically affect the activity of the Na+-phosphate carrier: the plasma phosphate concentration and parathyroid hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/45,50-52\">",
"     45,50-52",
"    </a>",
"    ]. A low-phosphate diet or hypophosphatemia, for example, leads to virtual abolition of phosphate excretion in the urine, an effect that is primarily mediated by increased activity of the type II cotransporter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. In mice without type II transporter genes, proximal phosphate transport with chronic phosphate deprivation is only 15 percent that of wild-type mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, Na+-phosphate carrier activity is diminished after a phosphate load [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/51\">",
"     51",
"    </a>",
"    ], resulting in an appropriate increase in urinary excretion. Although this in part represents a direct effect of the rise in plasma phosphate concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/51\">",
"     51",
"    </a>",
"    ], increased secretion of PTH also plays a contributory role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/44,54\">",
"     44,54",
"    </a>",
"    ]. Enhanced PTH release in this setting occurs because phosphate loading can reduce the plasma Ca2+ concentration by driving the following reaction to the right",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Ca2+ &nbsp;+ &nbsp;HPO42- &nbsp; &lt;&mdash;&gt; &nbsp; CaHPO4",
"   </p>",
"   <p>",
"    and can decrease the renal production of calcitriol, thereby removing the normal inhibitory effect of this hormone on the parathyroid gland [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/55,56\">",
"     55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another factor that can affect proximal phosphate reabsorption is metabolic acidosis. In this setting, transporter activity is diminished, leading to an increase in phosphate excretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/45\">",
"     45",
"    </a>",
"    ]. The phosphaturia is in part beneficial in that it enhances buffer excretion, thereby allowing more acid to be excreted (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12762?source=see_link&amp;anchor=H9#H9\">",
"     \"Chapter 11A: Renal hydrogen excretion\", section on 'Titratable acidity'",
"    </a>",
"    ). Two factors may be involved in this response: direct inhibition of the Na+-phosphate cotransporter as the affinity for the Na+ interaction is reduced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/46\">",
"     46",
"    </a>",
"    ]; and, due to the fall in tubular fluid pH, conversion of HPO42- to H2PO4-, which has a lower affinity for the phosphate binding site on the cotransporter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/45,57\">",
"     45,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MAGNESIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circulating Mg2+ is partially protein-bound so that only about 70 to 80 percent is filtered across the glomerulus. In general, about 3 percent of the filtered Mg2+ escapes reabsorption in humans and is excreted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. This value is appropriately increased after a Mg2+ load and falls to very low levels with Mg2+ depletion. In contrast to other solutes, however, most of the filtered Mg2+ (50 to 60 percent) is reabsorbed in the cortical thick ascending limb of the loop of Henle and distal convoluted tubule, not in the proximal tubule (20 to 30 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/58\">",
"     58",
"    </a>",
"    ]. Furthermore, alterations in Mg2+ excretion are primarily due to changes in loop transport. As an example, a low Mg2+ diet leads to a rapid fall in Mg2+ excretion that is due to enhanced loop Mg2+ reabsorption and that may occur even before there is a fall in the plasma Mg2+ concentration or in the filtered Mg2+ load [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cellular mechanisms of Mg2+ transport in the thick ascending limb are incompletely understood. The bulk of Mg2+ transport appears to be passive, occurring by paracellular diffusion between the cells and being driven by the favorable electrical gradient resulting from the reabsorption of sodium chloride (",
"    <a class=\"graphic graphic_figure graphicRef75301 \" href=\"mobipreview.htm?30/62/31725\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/58,59,61\">",
"     58,59,61",
"    </a>",
"    ]. Paracellular magnesium reabsorption at this site appears to be facilitated by a tight junction protein called paracellin-1 or claudin-16 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors controlling Mg2+ transport act through changes on the voltage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    permeability of the paracellular pathway. Thus, decreased reabsorption and Mg2+ wasting can be induced by the administration of a loop diuretic, which inhibits sodium and chloride reabsorption, or by mutations in the paracellin-1 gene, which encodes the claudin-16 protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/22,62\">",
"     22,62",
"    </a>",
"    ]. Since claudin-16 appears to mediate the passive reabsorption of calcium as well as magnesium, patients with mutations present with renal magnesium and calcium wasting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/22,62\">",
"     22,62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/41/15000?source=see_link\">",
"     \"Causes of hypomagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Magnesium transport in the cortical thick ascending limb is also influenced by variations in the plasma magnesium",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    calcium concentrations in a manner that permits Mg2+ reabsorption to vary appropriately with Mg2+ intake. This regulatory process is mediated in part by a calcium (and magnesium) sensing receptor located in the basolateral membrane of thick ascending limb cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/34\">",
"     34",
"    </a>",
"    ]. Binding of calcium or magnesium to the extracellular domain of the receptor initiates a series of intracellular signals, which result in the inhibition of apical (luminal) potassium channels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/34,63\">",
"     34,63",
"    </a>",
"    ]. The latter effect will inhibit sodium chloride reabsorption, thereby increasing Mg2+ excretion by preventing the generation of passive gradients for Mg2+ reabsorption. This process is reversed by hypomagnesemia, resulting in a marked increase in loop reabsorption and a reduction in urinary excretion.",
"   </p>",
"   <p>",
"    In addition to paracellular transport in the thick ascending limb, Mg2+ handling also involves an active transcellular process in the distal convoluted tubule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/58,64\">",
"     58,64",
"    </a>",
"    ]. This process may be activated by changes in the plasma Mg2+ concentration and may occur via a",
"    <span class=\"nowrap\">",
"     Na+/Mg2+",
"    </span>",
"    exchanger.",
"   </p>",
"   <p>",
"    A number of hormones, including ADH, parathyroid hormone, glucagon, calcitonin, and &szlig;-adrenergic agonists, can stimulate Mg2+ reabsorption in the cortical thick ascending limb and distal convoluted tubule via the generation of cyclic AMP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. It is not likely, however, that these responses play an important role in Mg2+ regulation, since the secretion of these hormones is not affected by alterations in Mg2+ balance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     URIC ACID",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uric acid is formed from metabolism of purine nucleotides. With a pKa of about 5.35, the reaction",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Uric acid &nbsp; &lt;&mdash;&gt; &nbsp; &nbsp;Urate- &nbsp;+ &nbsp;H+",
"   </p>",
"   <p>",
"    is shifted far to the right at the normal arterial pH of 7.40. As a result, most uric acid circulates as the urate anion. Filtered urate is handled entirely in the proximal tubule, where three separate processes are involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/67-69\">",
"     67-69",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reabsorption of most of the filtered urate in the early proximal tubule",
"     </li>",
"     <li>",
"      Tubular secretion by the organic anion secretory pathway in the mid-proximal tubule of an amount normally equal to about 50 percent of the filtered load",
"     </li>",
"     <li>",
"      Postsecretory reabsorption of most of the secreted urate in the late proximal tubule.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The net effect is the excretion of 6 to 12 percent of the amount filtered. Alterations in excretion according to urate homeostasis are thought to be mediated primarily by changes in the rate of tubular secretion.",
"   </p>",
"   <p>",
"    Uric acid is ultimately transported via the actions of multiple anion exchangers at the basolateral and luminal membranes. Energy for uric acid transport is provided by the Na+-K+-ATPase pump, which maintains a low cell Na+ concentration, thereby creating a concentration gradient favoring passive Na+ entry into the cell. Citric acid cycle intermediates (particularly alpha-ketoglutarate) can enter the cell by cotransport with sodium across the basolateral membrane (via the sodium-dicarboxylate symporter [NaDC-3]) and are also produced within the cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/70\">",
"     70",
"    </a>",
"    ]. The intracellular accumulation of alpha-ketoglutarate creates a favorable outward gradient for this compound that can then be used to drive the entry of uric acid into the cell via the organic anion transporter (OAT) 1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of OATs in the basolateral membrane have been characterized",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cloned. All three OATs may contribute to urate entry into the cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the luminal membrane, urate is reabsorbed via anion exchange by a urate organic anion countertransporter (URAT1) that is encoded by the SLC22A12 gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/71\">",
"     71",
"    </a>",
"    ]. Defects in this exchanger are responsible for idiopathic renal hypouricemia, an autosomal recessive disorder associated with extremely low serum levels of uric acid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/71\">",
"     71",
"    </a>",
"    ]. Uptake of urate via URAT1 is also inhibited by a large number of drugs implicated in uric acid balance. These include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/18/37157?source=see_link\">",
"     probenecid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    , and some nonsteroidal anti-inflammatory agents.",
"   </p>",
"   <p>",
"    Although these models explain how urate can be transported, it still remains uncertain why urate is reabsorbed in the early and late portions of the proximal tubule and is secreted in the mid-portion. One hypothesis is that net urate reabsorption or secretion within an anatomic segment is determined by the absolute number of reabsorption or secretion transporters located within the membranes of these segments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Net urate reabsorption also varies directly with proximal Na+ transport and, in the presence of volume depletion, both Na+ and urate excretion are reduced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/72\">",
"     72",
"    </a>",
"    ]. The mechanism by which urate handling is affected in this setting is incompletely understood.",
"   </p>",
"   <p>",
"    Regardless of the mechanism, increased net proximal reabsorption is responsible for the elevation in the plasma urate concentration (hyperuricemia) frequently seen in patients on diuretic therapy. If, however, the diuretic-induced Na+ and water losses are replaced, hyperuricemia does not develop, since there is no stimulus to Na+ retention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PROTEINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Filtered proteins are almost entirely reabsorbed in the proximal tubule. Several mechanisms are involved in this process as proteins of different sizes have different transport systems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/74-76\">",
"     74-76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Amino acids primarily enter the cell by cotransport with sodium and then are returned to the systemic circulation by facilitated diffusion across the basolateral membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. There are several different sodium-dependent amino acid carriers, each of which recognizes different groups of amino acids.",
"   </p>",
"   <p>",
"    There are also sodium-independent transporters for neutral amino acids (such as leucine, isoleucine, and phenylalanine) and for cystine and other dibasic amino acids (ornithine, arginine, and lysine) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. Mutations in the gene named SCL3A1, which encodes a protein that mediates sodium-independent transport of cystine and dibasic acids in the proximal tubule and small intestine, are responsible for \"classic\" cystinuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. This disorder is characterized by diminished reabsorption of cystine and the formation of cystine stones, since cystine is poorly soluble in urine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25577?source=see_link\">",
"     \"Cystine stones\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are also Na+-dependent cotransporters in the basolateral membrane that allow some amino acids (such as glycine and glutamine) to enter the cell at both membranes. The physiologic importance of this effect is incompletely understood. The increased entry of glutamine may play a role in acid-base balance, since this amino acid is the primary source of ammonium production in the proximal tubule. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12762?source=see_link&amp;anchor=H10#H10\">",
"     \"Chapter 11A: Renal hydrogen excretion\", section on 'Ammonium excretion'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Larger proteins are handled differently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. Small peptides, such as angiotensin II, are hydrolyzed by brush border peptidases, and the amino acids are then reabsorbed. Larger compounds, such as insulin and lysozyme, enter the cell by carrier-mediated endocytosis and are then transported into lysosomes where they are metabolized to amino acids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/74,83\">",
"     74,83",
"    </a>",
"    ]. The efficiency of endocytosis is in part dependent upon molecular charge, with proteins that are cationic (that is, proteins that have an isoelectric point above that of the urine pH) being reabsorbed more completely than those that are anionic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/74,83,84\">",
"     74,83,84",
"    </a>",
"    ]. This charge-dependence may reflect more avid binding of cationic proteins to anionic phospholipids in the luminal membrane.",
"   </p>",
"   <p>",
"    In addition, albumin can be reabsorbed by a second, low-affinity, high-capacity endocytic process when it is filtered in greater than normal amounts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/85\">",
"     85",
"    </a>",
"    ]. This most commonly occurs in the nephrotic syndrome, in which enhanced reabsorption and subsequent catabolism of filtered albumin may contribute to the associated hypoalbuminemia.",
"   </p>",
"   <p>",
"    The net effect of proximal reabsorption and catabolism of proteins is twofold: (1) the preservation of nitrogen balance by minimizing urinary losses; and (2) participation in hormonal homeostasis, since the kidney is a major site of metabolism for polypeptide hormones such as insulin, gastrin, and glucagon&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CITRATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;In normal subjects, 65 to 90 percent of the filtered citrate is reabsorbed by, and then mostly metabolized in, the proximal tubule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/86\">",
"     86",
"    </a>",
"    ]. As with the uptake of most other solutes, the entry of filtered citrate into the proximal tubular cells is dependent upon the favorable electrochemical gradient for Na+, being mediated by a 3Na+: 1citrate2- cotransporter in the luminal membrane, also called the",
"    <span class=\"nowrap\">",
"     Na+/dicarboxylate",
"    </span>",
"    cotransporter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/86-88\">",
"     86-88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An important determinant of net citrate reabsorption is the state of acid-base balance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/86,89\">",
"     86,89",
"    </a>",
"    ]. Acidemia is associated with increased proximal citrate reabsorption. This change may be appropriate from the viewpoint of acid-base balance. The metabolism of each meq of citrate generates 3 meq of bicarbonate; thus, increasing citrate reabsorption with acidemia is beneficial in that in prevents the loss of alkali in the urine, a change that would further lower the extracellular pH.",
"   </p>",
"   <p>",
"    The relationship between acid-base balance and citrate handling is in part due to the fall in luminal pH which promotes the conversion of citrate3-, the major circulating form, into citrate2-, which appears to be more easily reabsorbed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/89\">",
"     89",
"    </a>",
"    ]. The associated intracellular acidosis also enhances citrate entry into the mitochondria (via an unknown mechanism); the ensuing reduction in the cytosolic citrate concentration creates a more favorable gradient for citrate reabsorption from the tubular lumen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/86\">",
"     86",
"    </a>",
"    ]. These changes are reversed by alkalemia, which diminishes citrate reabsorption and therefore increases urinary citrate excretion.",
"   </p>",
"   <p>",
"    In addition to metabolic acidosis, hypokalemia is another condition in which proximal citrate reabsorption in enhanced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/90\">",
"     90",
"    </a>",
"    ]. A somewhat similar mechanism may be involved, since the loss of K+ leads to a transcellular cation exchange in which K+ leaves the cells to replete the extracellular stores and, to maintain electroneutrality, H+ and Na+ enter the cells. The ensuing intracellular acidosis may be responsible for the increased citrate reabsorption.",
"   </p>",
"   <p>",
"    Citrate handling becomes clinically important in some patients who form calcium stones. Citrate is a potent inhibitor of calcium oxalate and calcium phosphate precipitation, by combining with free Ca2+ to form a nondissociable but soluble complex. Hypocitraturia is a risk factor for stone disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/38,91,92\">",
"     38,91,92",
"    </a>",
"    ] and can be corrected by the administration of alkali. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/2/38953?source=see_link\">",
"     \"Prevention of recurrent calcium stones in adults\"",
"    </a>",
"    .)&nbsp;Potassium citrate has most often been used in this setting, because it has two advantages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. First, citrate (which is rapidly metabolized to bicarbonate) is generally better tolerated than bicarbonate, which can cause gastrointestinal symptoms due to local gas formation. Second, the potassium salt is preferred because sodium citrate will produce volume expansion, which, as described above, will increase Na+ and secondarily Ca2+ excretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/2/36905/abstract/93\">",
"     93",
"    </a>",
"    ]. The latter effect could negate any stone-preventing benefit derived from the rise in citrate excretion.",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15684?source=see_link\">",
"     \"Chapter 3C: Secretory pathways in proximal tubule\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/1\">",
"      DIRKS JH, CIRKSENA WJ, BERLINER RW. THE EFFECTS OF SALINE INFUSION ON SODIUM REABSORPTION BY THE PROXIMAL TUBULE OF THE DOG. J Clin Invest 1965; 44:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/2\">",
"      Purkerson ML, Lubowitz H, White RW, Bricker NS. On the influence of extracellular fluid volume expansion on bicarbonate reabsorption in the rat. J Clin Invest 1969; 48:1754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/3\">",
"      Kurtzman NA. Regulation of renal bicarbonate reabsorption by extracellular volume. J Clin Invest 1970; 49:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/4\">",
"      Burnham CE, Amlal H, Wang Z, et al. Cloning and functional expression of a human kidney Na+:HCO3- cotransporter. J Biol Chem 1997; 272:19111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/5\">",
"      Gamba G. Alternative splicing and diversity of renal transporters. Am J Physiol Renal Physiol 2001; 281:F781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/6\">",
"      Sacktor B. Sodium-coupled hexose transport. Kidney Int 1989; 36:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/7\">",
"      Turner RJ, Moran A. Heterogeneity of sodium-dependent D-glucose transport sites along the proximal tubule: evidence from vesicle studies. Am J Physiol 1982; 242:F406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/8\">",
"      Thorens B, Lodish HF, Brown D. Differential localization of two glucose transporter isoforms in rat kidney. Am J Physiol 1990; 259:C286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/9\">",
"      Dominguez JH, Camp K, Maianu L, Garvey WT. Glucose transporters of rat proximal tubule: differential expression and subcellular distribution. Am J Physiol 1992; 262:F807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/10\">",
"      Ruegg CE, Mandel LJ. Bulk isolation of renal PCT and PST. II. Differential responses to anoxia or hypoxia. Am J Physiol 1990; 259:F176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/11\">",
"      Wells RG, Pajor AM, Kanai Y, et al. Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter. Am J Physiol 1992; 263:F459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/12\">",
"      Kanai Y, Lee WS, You G, et al. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest 1994; 93:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/13\">",
"      OLIVER J, MACDOWELL M. The structural and functional aspects of the handling of glucose by the nephrons and the kidney and their correlation by means of structural-functional equivalents. J Clin Invest 1961; 40:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/14\">",
"      Elsas LJ, Rosenberg LE. Familial renal glycosuria: a genetic reappraisal of hexose transport by kidney and intestine. J Clin Invest 1969; 48:1845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/15\">",
"      Roth KS, Foreman JW, Segal S. The Fanconi syndrome and mechanisms of tubular transport dysfunction. Kidney Int 1981; 20:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/16\">",
"      Woolf LI, Goodwin BL, Phelps CE. T-m-limited renal tubular reabsorption and the genetics of renal glucosuria. J Theor Biol 1966; 11:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/17\">",
"      Dossetor JB. Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia. Ann Intern Med 1966; 65:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/18\">",
"      Sutton RA. Disorders of renal calcium excretion. Kidney Int 1983; 23:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/19\">",
"      Friedman PA, Gesek FA. Calcium transport in renal epithelial cells. Am J Physiol 1993; 264:F181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/20\">",
"      Ng RC, Rouse D, Suki WN. Calcium transport in the rabbit superficial proximal convoluted tubule. J Clin Invest 1984; 74:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/21\">",
"      Friedman PA. Basal and hormone-activated calcium absorption in mouse renal thick ascending limbs. Am J Physiol 1988; 254:F62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/22\">",
"      Simon DB, Lu Y, Choate KA, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999; 285:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/23\">",
"      Friedman PA, Gesek FA. Hormone-responsive Ca2+ entry in distal convoluted tubules. J Am Soc Nephrol 1994; 4:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/24\">",
"      Shimizu T, Yoshitomi K, Nakamura M, Imai M. Effects of PTH, calcitonin, and cAMP on calcium transport in rabbit distal nephron segments. Am J Physiol 1990; 259:F408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/25\">",
"      Bourdeau JE, Lau K. Regulation of cytosolic free calcium concentration in the rabbit connecting tubule: a calcium-absorbing renal epithelium. J Lab Clin Med 1992; 119:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/26\">",
"      Costanzo LS, Windhager EE. Effects of PTH, ADH, and cyclic AMP on distal tubular Ca and Na reabsorption. Am J Physiol 1980; 239:F478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/27\">",
"      Gesek FA, Friedman PA. On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 1992; 90:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/28\">",
"      Bacskai BJ, Friedman PA. Activation of latent Ca2+ channels in renal epithelial cells by parathyroid hormone. Nature 1990; 347:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/29\">",
"      Bouhtiauy I, Lajeunesse D, Christakos S, Brunette MG. Two vitamin D3-dependent calcium binding proteins increase calcium reabsorption by different mechanisms. II. Effect of CaBP 9K. Kidney Int 1994; 45:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/30\">",
"      Friedman PA, Gesek FA. Vitamin D3 accelerates PTH-dependent calcium transport in distal convoluted tubule cells. Am J Physiol 1993; 265:F300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/31\">",
"      Bindels RJ, Ramakers PL, Dempster JA, et al. Role of Na+/Ca2+ exchange in transcellular Ca2+ transport across primary cultures of rabbit kidney collecting system. Pflugers Arch 1992; 420:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/32\">",
"      Bouhtiauy I, Lajeunesse D, Brunette MG. The mechanism of parathyroid hormone action on calcium reabsorption by the distal tubule. Endocrinology 1991; 128:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/33\">",
"      Shimizu T, Nakamura M, Yoshitomi K, Imai M. Interaction of trichlormethiazide or amiloride with PTH in stimulating Ca2+ absorption in rabbit CNT. Am J Physiol 1991; 261:F36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/34\">",
"      Hebert SC. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 1996; 50:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/35\">",
"      Kurokawa K. Calcium-regulating hormones and the kidney. Kidney Int 1987; 32:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/36\">",
"      Winer KK, Yanovski JA, Cutler GB Jr. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 1996; 276:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/37\">",
"      Martinez-Maldonado M, Eknoyan G, Suki WN. Diuretics in nonedematous states. Physiological basis for the clinical use. Arch Intern Med 1973; 131:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/38\">",
"      Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/39\">",
"      Breslau N, Moses AM, Weiner IM. The role of volume contraction in the hypocalciuric action of chlorothiazide. Kidney Int 1976; 10:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/40\">",
"      Costanzo LS. Localization of diuretic action in microperfused rat distal tubules: Ca and Na transport. Am J Physiol 1985; 248:F527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/41\">",
"      Gesek FA, Friedman PA. Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest 1992; 90:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/42\">",
"      Brunette MG, Mailloux J, Lajeunesse D. Calcium transport through the luminal membrane of the distal tubule. I. Interrelationship with sodium. Kidney Int 1992; 41:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/43\">",
"      Murer H, L&ouml;tscher M, Kaissling B, et al. Renal brush border membrane Na/Pi-cotransport: molecular aspects in PTH-dependent and dietary regulation. Kidney Int 1996; 49:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/44\">",
"      Biber J, Custer M, Magagnin S, et al. Renal Na/Pi-cotransporters. Kidney Int 1996; 49:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/45\">",
"      Murer H. Homer Smith Award. Cellular mechanisms in proximal tubular Pi reabsorption: some answers and more questions. J Am Soc Nephrol 1992; 2:1649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/46\">",
"      Busch A, Waldegger S, Herzer T, et al. Electrophysiological analysis of Na+/Pi cotransport mediated by a transporter cloned from rat kidney and expressed in Xenopus oocytes. Proc Natl Acad Sci U S A 1994; 91:8205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/47\">",
"      Walker JJ, Yan TS, Quamme GA. Presence of multiple sodium-dependent phosphate transport processes in proximal brush-border membrane. Am J Physiol 1987; 252:F226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/48\">",
"      Tenenhouse HS. Recent advances in epithelial sodium-coupled phosphate transport. Curr Opin Nephrol Hypertens 1999; 8:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/49\">",
"      Beck L, Karaplis AC, Amizuka N, et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A 1998; 95:5372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/50\">",
"      Kempson SA, Shah SV, Werness PG, et al. Renal brush border membrane adaptation to phosphorus deprivation: effects of fasting versus low-phosphorus diet. Kidney Int 1980; 18:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/51\">",
"      Cheng L, Dersch C, Kraus E, et al. Renal adaptation to phosphate load in the acutely thyroparathyroidectomized rat: rapid alteration in brush border membrane phosphate transport. Am J Physiol 1984; 246:F488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/52\">",
"      Hammerman MR, Karl IE, Hruska KA. Regulation of canine renal vesicle Pi transport by growth hormone and parathyroid hormone. Biochim Biophys Acta 1980; 603:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/53\">",
"      Hoag HM, Martel J, Gauthier C, Tenenhouse HS. Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)/phosphate cotransport and cotransporter gene expression. J Clin Invest 1999; 104:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/54\">",
"      Hruska KA, Klahr S, Hammerman MR. Decreased luminal membrane transport of phosphate in chronic renal failure. Am J Physiol 1982; 242:F17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/55\">",
"      Reiss E, Canterbury JM, Bercovitz MA, Kaplan EL. The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest 1970; 49:2146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/56\">",
"      Portale AA, Halloran BP, Morris RC Jr. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 1987; 80:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/57\">",
"      Quamme GA. Effect of pH on Na(+)-dependent phosphate transport in renal outer cortical and outer medullary BBMV. Am J Physiol 1990; 258:F356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/58\">",
"      Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int 1997; 52:1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/59\">",
"      de Rouffignac C, Quamme G. Renal magnesium handling and its hormonal control. Physiol Rev 1994; 74:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/60\">",
"      Shafik IM, Quamme GA. Early adaptation of renal magnesium reabsorption in response to magnesium restriction. Am J Physiol 1989; 257:F974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/61\">",
"      Shareghi GR, Agus ZS. Magnesium transport in the cortical thick ascending limb of Henle's loop of the rabbit. J Clin Invest 1982; 69:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/62\">",
"      Kausalya PJ, Amasheh S, G&uuml;nzel D, et al. Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16. J Clin Invest 2006; 116:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/63\">",
"      Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996; 271:C103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/64\">",
"      Bapty BW, Dai LJ, Ritchie G, et al. Extracellular Mg2(+)- and Ca2(+)-sensing in mouse distal convoluted tubule cells. Kidney Int 1998; 53:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/65\">",
"      De Rouffignac C, Di Stefano A, Wittner M, et al. Consequences of differential effects of ADH and other peptide hormones on thick ascending limb of mammalian kidney. Am J Physiol 1991; 260:R1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/66\">",
"      Dai LJ, Bapty B, Ritchie G, Quamme GA. Glucagon and arginine vasopressin stimulate Mg2+ uptake in mouse distal convoluted tubule cells. Am J Physiol 1998; 274:F328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/67\">",
"      Kahn AM. Effect of diuretics on the renal handling of urate. Semin Nephrol 1988; 8:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/68\">",
"      Kahn AM. Indirect coupling between sodium and urate transport in the proximal tubule. Kidney Int 1989; 36:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/69\">",
"      Guggino SE, Martin GJ, Aronson PS. Specificity and modes of the anion exchanger in dog renal microvillus membranes. Am J Physiol 1983; 244:F612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/70\">",
"      Burckhardt BC, Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 2003; 146:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/71\">",
"      Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/72\">",
"      Weinman EJ, Eknoyan G, Suki WN. The influence of the extracellular fluid volume on the tubular reabsorption of uric acid. J Clin Invest 1975; 55:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/73\">",
"      Steele TH, Oppenheimer S. Factors affecting urate excretion following diuretic administration in man. Am J Med 1969; 47:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/74\">",
"      Carone FA, Peterson DR. Hydrolysis and transport of small peptides by the proximal tubule. Am J Physiol 1980; 238:F151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/75\">",
"      Daniel H, Herget M. Cellular and molecular mechanisms of renal peptide transport. Am J Physiol 1997; 273:F1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/76\">",
"      Palac&iacute;n M, Est&eacute;vez R, Bertran J, Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 1998; 78:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/77\">",
"      Zelikovic I, Chesney RW. Sodium-coupled amino acid transport in renal tubule. Kidney Int 1989; 36:351.",
"     </a>",
"    </li>",
"    <li>",
"     Chillaron, J, Roca, R, Valencia, A, Zorzano, A. Heteromeric amino acid transporters: Biochemistry, genetics, and physiology. Am J Physiol Renal Physiol 2001: 50:F995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/79\">",
"      Tate SS, Yan N, Udenfriend S. Expression cloning of a Na(+)-independent neutral amino acid transporter from rat kidney. Proc Natl Acad Sci U S A 1992; 89:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/80\">",
"      Kanai Y, Stelzner MG, Lee WS, et al. Expression of mRNA (D2) encoding a protein involved in amino acid transport in S3 proximal tubule. Am J Physiol 1992; 263:F1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/81\">",
"      Calonge MJ, Gasparini P, Chillar&oacute;n J, et al. Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet 1994; 6:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/82\">",
"      Palac&iacute;n M, Est&eacute;vez R, Zorzano A. Cystinuria calls for heteromultimeric amino acid transporters. Curr Opin Cell Biol 1998; 10:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/83\">",
"      Olbricht CJ, Gutjahr E, Cannon JK, et al. Effect of low molecular weight proteins and dextran on renal cathepsin B and L activity. Kidney Int 1990; 37:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/84\">",
"      Christensen EI, Rennke HG, Carone FA. Renal tubular uptake of protein: effect of molecular charge. Am J Physiol 1983; 244:F436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/85\">",
"      Park CH, Maack T. Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest 1984; 73:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/86\">",
"      Hamm LL. Renal handling of citrate. Kidney Int 1990; 38:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/87\">",
"      J&oslash;rgensen KE, Kragh-Hansen U, R&oslash;igaard-Petersen H, Sheikh MI. Citrate uptake by basolateral and luminal membrane vesicles from rabbit kidney cortex. Am J Physiol 1983; 244:F686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/88\">",
"      Pajor AM. Citrate transport by the kidney and intestine. Semin Nephrol 1999; 19:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/89\">",
"      Brennan S, Hering-Smith K, Hamm LL. Effect of pH on citrate reabsorption in the proximal convoluted tubule. Am J Physiol 1988; 255:F301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/90\">",
"      Levi M, McDonald LA, Preisig PA, Alpern RJ. Chronic K depletion stimulates rat renal brush-border membrane Na-citrate cotransporter. Am J Physiol 1991; 261:F767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/91\">",
"      Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 1986; 30:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/92\">",
"      Pak CY, Peterson R, Sakhaee K, et al. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am J Med 1985; 79:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/2/36905/abstract/93\">",
"      Sakhaee K, Nicar M, Hill K, Pak CY. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int 1983; 24:348.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7281 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C9BE2142DC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36905=[""].join("\n");
var outline_f36_2_36905=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BICARBONATE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Relation of TmHCO3- to sodium transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Glucose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Urea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CALCIUM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PHOSPHATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MAGNESIUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      URIC ACID",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PROTEINS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CITRATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7281\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7281|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/61/43997\" title=\"figure 1\">",
"      TmHCO3 in normals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/50/26413\" title=\"figure 2\">",
"      TmHCO3 without volume expansion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/30/38381\" title=\"figure 3\">",
"      TmGlucose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/27/37309\" title=\"figure 4\">",
"      Distal tubule transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/62/31725\" title=\"figure 5\">",
"      Loop of Henle transport",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/41/15000?source=related_link\">",
"      Causes of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12762?source=related_link\">",
"      Chapter 11A: Renal hydrogen excretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/55/21368?source=related_link\">",
"      Chapter 2E: Clinical evaluation of the renal circulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15684?source=related_link\">",
"      Chapter 3C: Secretory pathways in proximal tubule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2631?source=related_link\">",
"      Chapter 6F: Hormonal regulation of calcium and phosphate balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25577?source=related_link\">",
"      Cystine stones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/28/10692?source=related_link\">",
"      Pathogenesis of metabolic alkalosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/2/38953?source=related_link\">",
"      Prevention of recurrent calcium stones in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_2_36906="Guide for lateral cervical spine x-ray";
var content_f36_2_36906=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 692px\">",
"   <div class=\"ttl\">",
"    Guide for lateral cervical spine x-ray",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 672px; height: 683px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mower WR, Hoffman JR, Mahadevan SV. Cervical spine fractures. In: Harwood-Nuss Clinical Practice of Emergency Medicine, 5th ed, Wolfson AB (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2009. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36906=[""].join("\n");
var outline_f36_2_36906=null;
var title_f36_2_36907="Potential indications for using emergency contraception";
var content_f36_2_36907=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potential indications for using emergency contraception",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        When no contraceptive was used during sexual intercourse within the previous 120 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        When there is a contraceptive failure or incorrect use of a contraceptive within the previous 120 hours, including:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Condom breakage, slippage, or incorrect use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Three or more 30 to 35 mcg ethinyl estradiol pills have been missed (or two or more 20 to 25 mcg pills)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Progestin-only pill (minipill) taken more than three hours late",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        More than two weeks late for injection of depot-medroxyprogesterone acetate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Dislodgment, breakage, tearing, or early removal of a diaphragm or cervical cap",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Dislodgment, delay in placing, or early removal of a contraceptive hormonal skin patch or vaginal ring",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Failed coitus interruptus (eg, ejaculation in vagina or on external genitalia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Failure of a spermicide tablet or film to melt before sexual intercourse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Miscalculation of the periodic abstinence method or failure to abstain on fertile day of cycle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Expulsion of intrauterine contraception",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * We suggest the simpler recommendation that emergency contraception be used after two missed pills, regardless of dose.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: World Health Organization fact sheet No. 244 on Emergency Contraception. 2005.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36907=[""].join("\n");
var outline_f36_2_36907=null;
var title_f36_2_36908="Initial ATA risk of recurrence classification";
var content_f36_2_36908=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F52272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F52272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Initial American Thyroid Association risk of recurrence classification",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Low risk",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            All of the following are present:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            No local or distant metastases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            All macroscopic tumor has been resected",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            No invasion of locoregional tissues",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Tumor does not have aggressive histology (eg, tall cell, insular, columnar cell carcinoma, Hurthle cell carcinoma, follicular thyroid cancer)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            No vascular invasion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            No",
"            <sup>",
"             131",
"            </sup>",
"            I uptake outside the thyroid bed on the post-treatment scan, if done",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Intermediate risk",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Any of the following is present:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Microscopic invasion into the perithyroidal soft tissues",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cervical lymph node metastases or",
"            <sup>",
"             131",
"            </sup>",
"            I uptake outside the thyroid bed on the post-treatment scan done after thyroid remnant ablation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Tumor with aggressive histology or vascular invasion (eg, tall cell, insular, columnar cell carcinoma, Hurthle cell carcinoma, follicular thyroid cancer)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            High risk",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Any of the following is present:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Macroscopic tumor invasion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Incomplete tumor resection with gross residual disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Distant metastases",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tuttle RM, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010; 20:1341. Copyright &copy; 2010 Mary Ann Liebert, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36908=[""].join("\n");
var outline_f36_2_36908=null;
var title_f36_2_36909="High fiber diet guidelines B";
var content_f36_2_36909=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50180&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50180&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    High fiber diet guidelines (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        High fiber diet guidelines from Texas Children's Hospital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Read labels on foods, and look for 3 or more grams of fiber per serving. Eat 3 or more servings each day of breads and cereals made from whole grains and bran. Eat 5 or more servings each day of fruits and vegetables, including beans. It is important to increase water in the diet when you increase fiber.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Meat, poultry, fish, milk, milk products, and fats such as oil, margarine, and salad dressings do not normally have fiber, but it is important to include these in your child's diet to provide a complete balance of foods.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        High fiber dry cereals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        One serving equals 1/2 cup.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Cereal",
"       </td>",
"       <td class=\"subtitle2\">",
"        Fiber, grams",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fiber One",
"       </td>",
"       <td>",
"        13",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 percent Bran",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All Bran",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bran Buds",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kashi Go&nbsp;Lean&nbsp;",
"       </td>",
"       <td>",
"        8 to 10&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kellogg's Complete Bran Flakes",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Grape Nuts",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raisin Bran*",
"       </td>",
"       <td>",
"        3 to 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cracklin' Oat Bran*",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 percent Whole Grain Wheat Chex",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fruit and Fibre",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Great Grains",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frosted Mini Wheats",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kellogg's Low Fat Granola",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cheerios",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wheaties",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        High fiber vegetables (cooked unless indicated)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        One serving of vegetables is 1/2 to 1 cup.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Vegetable",
"       </td>",
"       <td class=\"subtitle2\">",
"        Fiber, grams",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pinto, kidney, black, lima beans (1/2 cup)",
"       </td>",
"       <td>",
"        4 to 7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sweet potato (1 medium)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lentils (1/2 cup)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jicama (1/2 raw)",
"       </td>",
"       <td>",
"        3 to 4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Baked potato with skin (medium)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Corn (1/2 cup)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peas (1/2 cup)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Broccoli (1/2 cup)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cabbage (1/2 cup)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spinach (1/2 cup)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cauliflower (3/4 cup)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carrots (1 medium raw or 1/2 cup cooked)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        High fiber fruits",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        One serving of fruit is usually one piece.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Fruit",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"3\">",
"        Fiber, grams",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pear",
"       </td>",
"       <td colspan=\"3\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Strawberries (one cup)",
"       </td>",
"       <td colspan=\"3\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Apple (with skin)",
"       </td>",
"       <td colspan=\"3\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dried fruits like raisins (3 Tablespoons)",
"       </td>",
"       <td colspan=\"3\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Papaya",
"       </td>",
"       <td colspan=\"3\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peach (fresh)",
"       </td>",
"       <td colspan=\"3\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plums (2)",
"       </td>",
"       <td colspan=\"3\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mango",
"       </td>",
"       <td colspan=\"3\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nectarine",
"       </td>",
"       <td colspan=\"3\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avocado (1/2 medium)",
"       </td>",
"       <td colspan=\"3\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tomato (1 medium)",
"       </td>",
"       <td colspan=\"3\">",
"        2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    These guidelines are continued.",
"    <div class=\"footnotes\">",
"     * These cereals are also high in sugar (15 to 20 grams/serving).",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36909=[""].join("\n");
var outline_f36_2_36909=null;
var title_f36_2_36910="Thin blood smear 3";
var content_f36_2_36910=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thin blood smear 3",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36910=[""].join("\n");
var outline_f36_2_36910=null;
var title_f36_2_36911="Risks and benefits of MHT";
var content_f36_2_36911=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F87938&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F87938&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 533px\">",
"   <div class=\"ttl\">",
"    Risks and benefits of menopausal hormone therapy (MHT)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 513px; height: 702px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Risks and benefits of MHT in women starting MHT between the ages of 50 and 59 years or less than 10 years after the start of menopause. Data are expressed as the attributable (excess) risk or benefit for a woman taking E alone as MHT for five years.",
"    <br/>",
"    (B) Number of women per 1000 taking MHT for five years who are expected to have improvement of symptoms of vaginal atrophy or hot flashes.",
"    <br/>",
"    Design of panels A and B is the same. Note that the data regarding risks and benefits in the bottom of panel B represent those illustrated in panel A, where they are illustrated in expanded form so that they can be clearly seen. The purpose of reproducing these data in the bottom of panel B is to compare the number of women benefiting from relief of symptoms of hot flashes and vaginal atrophy with the number of women experiencing other risks and benefits.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Santen RJ, Allred DC, Ardoin SP. Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab 2010; 95:S1. Copyright &copy; 2009 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_2_36911=[""].join("\n");
var outline_f36_2_36911=null;
